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ABSTRACT 
Fishy-egg tainting has long been a problem associated with feeding canola meal (CM) to 
brown-shelled laying hens.  It is a classical example of nutrigenetics, as both dietary and 
genetic factors must be present for a hen to lay fishy-tainted eggs.  Trimethylamine 
(TMA), the compound responsible for the fishy smell, is produced by bacterial 
fermentation of choline in the lower gut.  CM contains large amounts of choline in the 
form of sinapine.  Choline must first be hydrolyzed from sinapine before it can be 
absorbed or converted to TMA.  Normally, the malodourous TMA is metabolized to the 
odourless trimethylamine N-oxide (TMAO) by flavin-containing monooxygenase 3 
(FMO3).  A mutation in FMO3 (c.984A>T) prevents TMA from being oxidized to 
TMAO, and subsequently TMA accumulates in the developing egg yolks.  Our objective 
was to determine the inheritance pattern of fishy-egg tainting when hens are fed canola 
meal, reflecting typical industry conditions.  In the first of two trials, hens of a 
commercial brown-shelled strain were genotyped at FMO3 c.984A>T and fed graded 
levels of CM (0, 6, 12, or 18%).  These hens were bred to produce a second generation 
of hens, which were also genotyped and fed graded levels of CM (0, 6, 12, 18, or 24%) 
or choline chloride (0, 0.055, 0.110, 0.165, or 0.220%).  Choline chloride, at levels up to 
0.220%, does not lead to the production of fishy tainted-eggs. When fed CM, TT hens 
laid fishy-tainted eggs.  Mean yolk TMA concentration was not significantly different 
between hens of the AA and AT genotypes, with means from both genotypes remaining 
below the human detection threshold for all of the dietary treatments.  Large day-to-day 
variations in yolk TMA concentration were seen in hens of all three genotypes.  We 
concluded that fishy-egg tainting is recessive when hens are fed CM at levels reflecting 
typical commercial practices. 
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1 INTRODUCTION 
Canola meal (CM) is an economical feed ingredient commonly used in laying 
hen diets.  Though it has a lower nutrient density than soybean meal, CM’s lower price 
and good amino acid balance make it a popular protein source in Canadian, European, 
and Australian poultry production (Hickling 2001).  With the demand for canola oil 
steadily increasing due to the advent of bio-diesel production, it is expected that the 
price of CM will decline, making it even more attractive to poultry producers (BBI 
Biofuels Canada 2006). 
The drawback of feeding CM to brown-shelled laying hens is that it causes the 
production of fishy-tainted eggs (Goh et al. 1984, Perez-Maldonado and Barram 2004).  
Consequently, CM is only included at low levels, if at all, in brown-shelled layer diets.  
Although brown-shelled eggs only make up a small portion of the total Canadian egg 
production, they form the majority of the market in areas such as Europe and Australia. 
Fishy-egg taint is an example of nutrigenetics, an up and coming field of study 
examining the effect of genotype on the response of an organism to dietary components 
(Pérusse 2008).  It should not be confused with the often-overlapping field of 
nutrigenomics, the study of the effects of nutrients on gene expression. 
The purpose of this study was to determine the mode of inheritance of fishy-egg 
tainting under typical production conditions.  This information will enable commercial 
breeding companies to produce taint-free hens, allowing producers to fully utilize CM as 
an economical feed ingredient. 
 2  
2 LITERATURE REVIEW 
2.1 Trimethylamine 
Trimethylamine (TMA), (CH3)3N (Figure 2.1a), is a tertiary amine that has a 
characteristic smell of rotting fish (Emmanuel et al. 1984, Hernandez et al. 2003).  It is 
highly volatile, with a boiling point of 2.87 ˚C (Aston et al. 1944).  It is the compound 
responsible for the fishy smell of tainted eggs (Hobson-Frohock et al. 1973).   
 
        
Figure 2.1 Diagrammatic representation of a) trimethylamine and b) trimethylamine N-
oxide. 
 
Trimethylamine N-oxide (TMAO), (CH3)3NO (Figure 2.1b), is an odourless 
metabolite of TMA (Pearson et al. 1979).  The melting point is 257 ˚C; therefore it is 
non-volatile (O’Neil et al. 2001).  The nitrogen-oxygen bond is semipolar in nature, and 
subsequently the TMAO is salt-like and less basic than TMA (Bickel 1969).   
a) b) 
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Whereas TMAO is readily filtered from the blood by the kidneys and excreted in 
the urine, TMA is more difficult to excrete and can subsequently accumulate in 
circulation and be deposited in developing follicles.  It is this accumulation of TMA that 
leads to fishy egg taint (Pearson et al. 1979).   
 
2.1.1 Chickens 
TMA can be found in follicular yolks of all sizes in the ovaries of taint-
producing hens (March and MacMillan 1979).   It has been shown that at least five days 
are necessary for tainted eggs to be produced after the introduction of a taint-inducing 
diet (March and MacMillan 1979).  This delay was due to the time necessary for TMA 
to accumulate in the yolk to a level high enough to be detected by smell. 
The first noted report of eggs with a fishy taint was by Vondell in 1932.  In a 
later report, Vondell (1948) stated that even though the diet is usually blamed as the 
source of the taint, “it apparently has no relation to the problem.”  However, subsequent 
studies have demonstrated that egg tainting is dependant upon both dietary and genetic 
factors (Bolton et al. 1976, Washburn 1990).  
The production of tainted eggs is characteristic to individual hens, and such hens 
are often found to have fishy-smelling breath (Vondell 1948, Miller et al. 1972).  The 
frequency upon which affected hens lay tainted eggs is variable; the eggs from some 
hens are consistently tainted, while those from other hens are tainted only sporadically 
(Vondell 1948).  Bolton et al. (1976) found that approximately one in five eggs 
produced by a tainting hen is tainted.  The frequency of tainted eggs produced by a flock 
generally decreases as the flock ages (Dänicke et al. 2006) and the occurrence has been 
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reported to be more prevalent during fall and early winter and declines into the spring 
(Vondell 1948, Miller et al. 1972). 
 
2.1.2 Humans 
In humans, trimethylaminuria (an accumulation of TMA that is also known as 
fishy-odour syndrome) is a recessively inherited condition (Dolphin et al. 1997a) and is 
caused by mutations in the flavin-containing monooxygenase 3 (FMO3) gene.  There are 
currently 16 known causative mutations in FMO3 that result in fishy-odour syndrome in 
humans, including three nonsense, 12 missense, and one large deletion (Hernandez et al. 
2003).   
Clinical diagnosis of trimethylaminuria is dependant upon urinary levels of TMA 
(unmetabolized) in comparison to TMAO (metabolized).  In unaffected individuals, 
TMA composes 0 to 9% of total urinary trimethylamines (i.e. TMA + TMAO), whereas 
TMA comprises greater than 40% of the total urinary trimethylamines in individuals 
with severe trimethylaminuria (Cashman et al. 2003).   
The mutations in FMO3 significantly reduce or eliminate the ability of the liver 
enzyme FMO3 to oxidize TMA into TMAO.  Affected individuals secrete TMA in their 
breath, sweat and saliva, causing them to emit a strong, fishy odour (Treacy et al. 1998).  
The loss of FMO3 function can also lead to problems in metabolizing tyramine (found in 
cheese) and some medications (Treacy et al. 1998).  
Similarly to chickens, dietary aspects can influence TMA metabolism in humans.  
Cashman et al. (1999) found that when healthy test subjects consumed Brussels sprouts 
for three weeks, the TMA to TMAO ratio of their urine increased by 2.6 to 3.2 times.  
 5  
They postulated that glucosinolates present in the Brussels sprouts inhibited the action of 
FMO3 in the liver.  Other vegetables of the Cruciferae family, such as cabbage, 
broccoli, and cauliflower, would likely produce the same effect.  
 
2.1.3 Dairy Cows 
A fishy flavour has been reported in milk from Swedish Red and White dairy 
cows (Lundén et al. 2002a and 2002b).  The occurrence of fishy taint in milk is often 
associated with cows grazing on wheat pasture (Mehta et al. 1974), although it has also 
been reported to occur in cows that have not been grazed on wheat (Lundén et al. 
2002a).  The production of tainted milk is intermittent but specific to individual cows 
within a herd (Lundén et al. 2002a). 
The fishy taint is due to high levels of TMA in the milk (Lundén et al. 2002a).  A 
possible source of the TMA is bacterial degradation of lecithin, choline, and/or betaine 
to TMAO because TMA is an intermediate product in these reactions (Eyer et al. 1990).   
Lundén et al. (2002a) found that TMA concentrations between 1 to 37 µg/g in 
milk resulted in a fishy taint.  They also found that the degree of taint is associated with 
TMA concentration in a dose-dependant manner.  The human detection threshold for 
TMA in milk is estimated to be 2 µg/g (Mehta et al. 1974).  Pasteurization does not 
improve the flavour of fishy-tainted milk (Mehta et al. 1974), but a drop in pH will 
cause TMA to be converted to trimethyl ammonium, which is not volatile and therefore 
does not result in a fishy taste (Lundén et al. 2002a). 
Lundén et al. (2002b) reported that the accumulation of TMA in milk is due to a 
nonsense mutation in the FMO3 gene of affected cattle.  A nucleotide substitution of C 
 6  
to T at nucleotide 62 of exon 6 causes a premature stop codon at amino acid position 
283, rendering the FMO3 enzyme non-functional.  It has been found in Swedish Red and 
White cattle, but not in the other dairy breeds tested, including Holstein, Jersey, and 
Swedish Polled.  Lundén et al. (2002b) hypothesized that milk taint is inherited 
recessively but heterozygotes can express the phenotype under certain environmental 
conditions.   
2.2 Canola Meal and Rapeseed Meal 
Rapeseed (Brassica napus and B. campestris) is a member of the mustard family, 
which also includes cabbage, turnips, Brussels sprouts, and several other vegetables 
(Shahidi 1990).  Rapeseed oil was used for centuries in Europe and Asia for soap 
making, lamp oil, and occasionally human consumption.  After the advent of the 
industrial revolution it was used as an industrial lubricant (National Research Council 
1992).  Prior to World War I rapeseed meal was used primarily as a fertilizer, then later 
at low concentrations in livestock diets (National Research Council 1992).   
Rapeseed is well adapted for growth on the Canadian prairies and has a relatively 
high oil content; these attributes made it an attractive candidate for the development of a 
new edible oil source after World War II (National Research Council 1992).  Rapeseed 
contains erucic acid (22 to 60% of the oil) and glucosinolates (0.30 to 0.63% of the 
meal), both of which are toxic and make the oil and meal unpalatable (Shahidi 1990, 
National Research Council 1992).  
 In the 1950’s an intensive breeding and selection program began in Canada to 
make rapeseed an appealing edible oil source (National Research Council 1992).  In 
1968 the first low erucic acid (less than 5%) variety was released and in 1974 the first 
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“double low” or low glucosinolate low erucic acid variety was licensed.  In 1979 all 
varieties in Canada containing less than 2% erucic acid and 30 µmol/g of glucosinolates 
were given the name “canola”.  Canola and rapeseed were officially recognized as 
different species by the US Food and Drug Administration in 1985, and canola was 
given the status as generally regarded as safe (Shahidi 1990). Canola oil is now a 
popular edible oil and canola meal is commonly used as a protein supplement in 
livestock rations (National Research Council 1992). 
 
2.2.1 Factors Affecting Fishy Egg Taint 
Feeding rapeseed meal (RSM) to brown-shell laying strains of hens has been 
reported in many instances to cause a fishy taint in some eggs (Hobson-Frohock et al. 
1975, Overfield and Elson 1975, Marangos and Hill 1976, Pearson et al. 1979).  
Overfield and Elson (1975) found that feeding RSM, even at levels as low as 3%, 
resulted in the production of fishy-tainted eggs from susceptible hens.  The fishy eggs 
appeared within 5 days of incorporating RSM into the diet.  Removal of RSM from the 
diet stopped the production of tainted eggs.  Egg tainting is still a problem with modern-
day canola meal, as Perez-Maldonado and Barram (2004) found that diets of 15 and 20% 
canola meal led to the production of fishy-tainted eggs when feed to brown-shelled 
layers. 
The incidence of tainting can decrease over time.  Overfield and Elson (1975) 
found that when RSM was fed for an extended period of time, the percentage of eggs 
that were tainted decreased substantially after 3 weeks on trial from 20 to 11%.  They 
theorized that the hens were able to adapt to the dietary factor that was causing the 
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production of tainted eggs.  They even went as far as to suggest that pullets reared on a 
diet containing RSM would not produce tainted eggs as adults.  March and MacMillan 
(1979) also found that the incidence of tainted eggs decreased substantially over time 
(27 weeks) when hens were maintained on a diet containing elevated levels of choline.  
They postulated that the hens might adapt to the presence of elevated choline levels in 
the diet.  Further study showed that this was not the case and they concluded that their 
original observations were due to the fact that taint-producing hens do not lay tainted 
eggs consistently.  They proposed that the inconsistency of tainted egg production could 
be due to shifts in the bacterial population of the small intestine and ceca. 
Rapeseed meal and canola meal (CM) inhibit the ability of some hens to oxidize 
TMA into TMAO.  Pearson et al. (1979) found that feeding RSM to taint-producing 
hens substantially reduced their ability to convert 14C-TMA into 14C-TMAO.  Tannins 
from RSM have been shown to reduce the ability of hens to oxidize TMA by up to 32% 
(Fenwick 1981).  The tannin content of low and high glucosinolate varieties of RSM is 
similar.  Dehulling rapeseed before processing into RSM would substantially decrease 
the tannin content of the meal, but the extra cost involved is not economically feasible 
(Fenwick 1981).  
Washburn (1990) states that although RSM is the “primary dietary factor 
influencing the production of tainted eggs, it is not the only one since the incidence in 
any individual bird is variable.”  Since RSM contains very little free TMA, it must 
contain a precursor to TMA in order to increase the circulating TMA levels in affected 
birds (Hobson-Frohock et al. 1975). 
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2.2.1.1 Glucosinolates 
Glucosinolates, also known as thioglucosides, are a type of antinutritional factor 
found in RSM (Bell and Belzile 1965) as well as canola meal, though at levels below 30 
µmol/g (Hickling 2001).  The major glucosinolate found in RSM and canola meal (CM) 
is sometimes called progoitrin because, it is converted to goitrin by the enzyme 
myrosinase.  Goitrin is a goitrogenic compound and its chemical name is (-)-5-vinyl-2-
oxazolidinethione (Bell and Belzile 1965).   
Myrosinase, also known as thioglucosidase, cleaves glucosinolates to yield 
isothiocyanates (specifically 3-butenyl and 4-pentenyl isothiocyanate in the case of 
RSM) as well as bisulfate and glucose (Bell and Belzile 1965). Myrosinase and 
glucosinolates are separated in intact rapeseeds but are able to combine when the seed is 
processed to form RSM (Josefsson 1972).  Myrosinase is also produced by enteric 
bacteria (Oginsky et al. 1965).  Goitrin is not a primary product of myrosinase activity.  
It is formed when isothiocyanates cyclize (Figure 2.2, Bell and Belzile 1965).  Goitrin 
formation is favored by heat treatment and extended storage (Josefsson 1972). 
Goitrin (from glucosinolates) inhibits the oxidation of TMA to TMAO (Goh et 
al. 1983, Goh et al. 1985).  Pearson et al. (1983) found that RSM from a low 
glucosinolate variety decreased hepatic TMA oxidase activity by 34%, but a high 
glucosinolate variety decreased activity by 77%.  The addition of glucosinolates to the 
low glucosinolate RSM diets yielded results similar to those of the high glucosinolate 
RSM diets.  It was concluded that the glucosinolates present in RSM depress hepatic 
TMA oxidase (i.e. FMO3) activity (Pearson et al. 1983, Goh et al. 1985).  Goitrin 
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inhibits the action of TMA oxidation by competing with TMA for the active site on 
FMO3 (Fenwick et al. 1981). 
 
 
Figure 2.2 Schematic representation of the involvement of glucosinolates in the 
development of fishy-egg taint.  Goitrin inhibits the oxidation of 
trimethylamine (TMA) to trimethylamine N-oxide (TMAO). 
 
RSM can increase thyroid size when fed to laying hens at concentrations above 
10% (Marangos and Hill 1976, Pearson et al. 1978, Ibrahim and Hill 1980). Due to the 
goitrogenic properties of RSM, it was postulated that the thyroid gland might be 
involved in egg tainting. Fenwick et al. (1981) found that including goitrin or a synthetic 
goitrogen in the diet of affected hens had the same effect as feeding RSM on depressing 
the conversion of 14C-TMA to 14C-TMAO.  They also found that injecting thyroid 
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hormones did not improve 14C-TMA metabolism.  They therefore concluded that the 
thyroid is not involved in fishy-egg taint. 
Pearson et al. (1983) found that susceptible hens still produced tainted eggs when 
fed a low glucosinolate variety of RSM.  They concluded that reducing the glucosinolate 
content of rapeseed alone would not be effective in eliminating egg tainting, and that 
another factor must be present in CM that leads to the production of fish-tainted eggs. 
 
2.2.1.2 Sinapine and Choline 
Sinapine is an ester of choline and 4-hydroxy-3, 5-dimethoxy-cinnamic acid, also 
known as sinapic acid (Figure 2.3, Pearson et al. 1980).  It is the major form of choline 
found in canola meal, present at approximately 1 to 2% (Lacki and Duvnjak 1996).  
Sinapine is hydrolyzed in the hindgut by enteric bacteria to yield choline and sinapic 
acid (Qiao and Classen 2003).  Qiao and Classen (2003) found that the apparent ileal 
digestibility of sinapine from RSM was 30-46%, whereas the fecal digestibility was 54-
63%, suggesting that the ceca are the major site of hydrolysis to choline and sinapic 
acid. 
 
  
Choline 
 
Sinapic  
Acid 
Ester Bond 
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Figure 2.3 Diagrammatic representation of sinapine (sinapic acid and choline joined by 
an ester bond).  Modified from Mabon et al. 1999. 
 
Decreases in the dietary level of sinapine led to decreases in the TMA content of 
eggs laid by tainting hens (Hobson-Frohock et al. 1977).  Goh et al. (1979a) found that 
including more than 0.1% sinapine in a RSM based diet led to the production of tainted 
eggs by susceptible hens.  They also found that the higher the level of sinapine in the 
diet, the less time it took for TMA to reach its maximum level in the eggs.  The sinapine 
content of RSM varies significantly with cultivar, therefore it may be possible to select 
for and develop a low sinapine variety of RSM (Mueller et al. 1978, Zum Felde et al. 
2007).   
Goh et al. (1979b) found that adding choline chloride to a laying diet did not lead 
to the production of tainted eggs, but adding bound choline in the form of sinapine did 
lead to the production of tainted eggs from susceptible hens.  They postulated that this 
was because choline chloride was readily absorbed by the small intestine and therefore 
was not available to TMA-producing bacteria in the ceca.  If the bacteria do not have 
access to the choline they cannot convert it to TMA and subsequently there is little or no 
TMA to absorb and be deposited in the eggs.   
According to March and MacMillan (1980), over 50% of the choline present in 
RSM is in a bound form.  They also found that on average the choline content of RSM 
was 5140 mg/kg compared to 1850 mg/kg in soybean meal.  Dänicke et al. (2006) found 
a significant relationship between the choline level of the diet and the occurrence of 
tainted eggs.   
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The choline requirement of laying hens is small, as they are able to synthesize 
large amounts of choline on their own (Crawford et al. 1969, Nesheim et al. 1971).  
Laying hens require approximately 120 mg of dietary choline per day for choline intake 
to equal output (Crawford et al. 1969).  A recent study by Dänicke et al. (2006) sets the 
minimum choline requirement for optimum laying performance at 1500 mg/kg of feed.  
It may be possible to decrease the amount of supplemental choline added to the diet (to 
reduce the potential for fishy taint) without impacting production parameters. 
2.2.1.2.1 Fermentation to Trimethylamine 
Enteric bacteria hydrolyze TMA from choline through the action of bacterial 
deaminase (Figure 2.4, March and MacMillan 1979, Butler and Fenwick 1984).  Gut 
bacteria convert choline exclusively to TMA, not other N-containing compounds (de la 
Huerga and Popper 1952). 
 
Figure 2.4 Diagrammatic representation of the hydrolysis of choline to trimethylamine 
(TMA) and ethylene glycol by bacterial deaminase.  Redrawn from Butler 
and Fenwick 1984. 
 
March and MacMillan (1979) found that the contents of the small intestine and 
ceca of both tainting and non-tainting hens consistently contained TMA. Concentrations 
of TMA were higher in the ceca than in the small intestine.  TMA concentrations in the 
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ceca were higher when the hens were fed diets containing RSM or supplementary 
choline, whereas levels in the small intestine were less influenced by the diet.  There was 
no association between the levels of TMA in the gut and TMA in the eggs.  However, 
Dänicke et al. (2006) found a linear relationship between the level of TMA in the 
excreta and in the egg yolk of hens fed excess amounts of choline.   
Adding antibiotics, such as neomycin and tetracycline, to the diet has been 
shown to reduce the incidence of egg tainting, suggesting that gram-positive enteric 
bacteria play a significant role in the production of TMA (Zentek and Kamphues 2002).  
Similar results have been found when aureomycin was administered orally to humans, 
though the inhibition of TMA production declined within a week of continuous 
administration and TMA levels returned to normal after two weeks (de la Huerga et al. 
1953).  No effect was seen when the antibiotic was administered intravenously. 
2.3 The Flavin-containing Monooxygenase Family 
The enzyme flavin-containing monooxygenase (FMO) was first reported by 
Ziegler and Mitchell in 1972.  At that time it was given the name microsomal mixed-
function amine oxidase, however in 1974 it was renamed to microsomal flavoprotein 
mixed-function oxidase when it was discovered that its substrates were not limited to 
nitrogenous compounds (Poulsen et al. 1974).  This enzyme was isolated from pig and 
human liver microsomes and was found to catalyze the N- and S-oxidation of a wide 
range of substrates.  It was present in much higher concentrations in the liver than in any 
other tissue (Ziegler and Poulsen 1978).   In 1984, it was discovered by Williams et al. 
that rabbit lung and liver contained distinctly different forms of FMO. 
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As more forms of FMO were discovered and found to be present in various 
tissues, the need developed for a standardized system of naming members of the FMO 
family.  Lawton et al. (1994) proposed a standard system of nomenclature for 
mammalian FMOs.  The flavin-containing monooxygenase gene family was termed 
FMO and each form was numbered sequentially in Arabic numerals (i.e. FMO1 through 
FMO6).   When referring to genes or mRNA the name is italicized (i.e. FMO1) and 
when referring to the protein the name is unitalicized (i.e. FMO1).  Hernandez et al. 
(2004) discovered several pseudo genes and proposed that they should have a lowercase 
‘p’ suffix (i.e. FMO7p) to differentiate them from functional genes.  No further work has 
been published on FMO pseudogenes, so it is not clear if the proposal by Hernandez et 
al. will become convention.   
2.3.1 Gene Family 
There are currently six recognized members of the FMO gene family, FMO1, 
FMO2, FMO3, FOM4, FMO5, and FMO6.  FMOs 1 through 5 give rise to functional 
proteins and FMO6 is a pseudogene (Hines et al. 2002).  Hernandez et al. (2004) 
documented an additional five pseudogenes in humans and named them FMP7p to 
FMO11p.   
In humans, FMO1 through FMO4 and FMO6 are located in a gene cluster on 
chromosome 1 in a region between 1q23 and 1q25 that spans approximately 2.2 Mbp 
(Figure 2.5, Shephard et al. 1993, McCombie et al. 1996, Hernandez et al. 2004).  
FMO5 is located further upstream at 1q21.1 (McCombie et al. 1996).  
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Figure 2.5 Representation of the FMO gene clusters on human chromosome 1.  Taken 
from Hernandez et al. 2004. 
 
The five functional FMOs (1 through 5) are very similar in gene structure; they 
all contain one or two 5’ non-coding exons and eight coding exons (Figure 2.6, 
Hernandez et al. 2004).  The size and intron/exon boundaries of the coding exons are 
highly conserved between the FMO genes (Hernandez et al. 2004).   
Expression of each FMO is tissue, developmental, species, and in some species 
(such as mice and rats) sex specific (Tynes and Philpot 1987, Cherrington et al. 1998, 
Koukouritaki et al. 2002).  Overby et al. (1997) found no correlation between the 
quantity of FMO mRNA and protein levels in humans, though others have found that 
transcription is a major factor in regulating FMO protein expression (Koukouritaki et al. 
2002, Zhang and Cashman 2006). 
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Figure 2.6 Structural representation of human FMO3.  Exons are represented by solid 
boxes and italicized numbers and introns by open boxes and bolded numbers 
in the upper portion of the figure.  The numbers in parentheses indicate the 
approximate sizes of the introns in kilobases.  The transcribed mRNA is 
depicted in the lower portion of the figure.  Shaded areas indicate 
untranslated regions and numbers indicate the nucleotide length of the coding 
portion of each exon.  Modified from Dolphin et al. 1997b. 
 
 
2.3.2 Structure and Function 
Flavin-containing monooxygenases (FMOs) catalyze the oxidation (and thus 
detoxification) of a wide range of soft nucleophiles, generally nitrogen of sulfur 
containing organic compounds (Ziegler and Poulson 1978).  Neutral compounds or those 
with a single positive charge are most likely to be substrates (Krueger and Williams 
2005).  These substrates include many xenobiotic toxins and pharmaceuticals (Ziegler 
1990).  Oxidation of these substrates generally reduces their toxicity and/or 
pharmacological activity (Krueger and Williams 2005).   
The crystalline structure of a yeast (Schizosaccharomyces pombe) FMO was 
reported by Eswaramoorthy et al. in 2006 (Figure 2.7).  The enzyme is composed of a 
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small and large structural domain separated by a channel.  The domains are joined by a 
large, randomly coiled loop, which is thought to stabilize the tertiary structure.  The 
large domain contains the FMO identifying sequence (FXGXXXHXXXF).  The flavin-
component, in the form of FAD, is present in the channel between the small and large 
domain.  The adenine of FAD forms hydrogen bonds with the GAGPSG motif (FAD 
binding sequence) that is present at the core of the large domain.  Three GXGXXG 
motifs also act to stabilize the FAD.  Similarly, the adenine of NADPH binds to the 
small domain via the GGASSA motif.  This bond is much weaker than the FAD bond.  
The flavin and nicotinamide bases form hydrogen bonds and interact with each other as 
part of the catalytic reaction of the enzyme (Eswaramoorthy et al. 2006).  The enzyme 
also contains a highly conserved FATGY motif, which is thought to be involved in 
substrate recognition (Stehr et al. 1998).  
In the first step of the catalytic reaction, NADPH+H+ is bound by the enzyme, 
which reduces the flavin-component (FAD) to FADH2 (Figure 2.7, Beaty and Ballou 
1981a and 1981b, Krueger and Williams 2005).  Oxygen then reacts with FADH2 to 
form flavin-hydroperoxide (FAD-OOH).  This form of FMO is stable and is how FMOs 
exist in the cell.  The enzyme is now “activated” and as soon as a substrate containing a 
soft nucleophile comes into contact with the FAD-OOH it is oxidized, no substrate 
binding is required.  The remaining hydroxyl group is converted to water and the 
NADP+ is released.  This is the rate-limiting step of the reaction.  The FAD is then free 
to be reduced and start the cycle over again. 
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Figure 2.7 Ribbon model of Schizosaccharomyces pombe flavin-containing 
monooxygenase bound to ball and stick model of FAD (Eswaramoorthy et al. 
2006).  The small and large domains are indicated, as well as the loop that 
joins them.  The FMO identifying sequence and FAD binding sequence are 
highlighted in blue. 
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Figure 2.8 Diagrammatic representation of the oxidative mechanism of flavin-containing 
monooxygenase, where S is the substrate before and SO is the substrate after 
oxidation.  Adapted from Kruger and Williams 2005. 
 
2.3.3 FMO3 
FMO3 is the enzyme responsible for the oxidation of TMA to TMAO (Lang et 
al. 1998, Zhang et al. 2007).  The oxidation of TMA and other nucleophilic substrates 
by FMO3 makes them polar, which subsequently allows them to be removed from 
circulation by the renal system (Cashman et al. 2000).  FMO3 is present in several 
tissues in the chicken, but by far the highest concentration is found in the liver 
(Honkatukia et al. 2005).   
2.3.3.1 Genetics of Egg Tainting 
The laying of fishy tainted eggs was found to be an individual hen characteristic 
(Vondell 1932).  Bolton et al. (1976) postulated that this was a genetic condition and 
that it was an autosomal semi-dominant (i.e. additive) gene with variable expression 
dependent upon environmental factors.  Pearson and Butler (1979) found that the TMA 
oxidation defect was present in both male and female chicks and there was no difference 
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between the sexes in regards to their sensitivity to rapeseed meal.  Although fishy-egg 
tainting is predominantly associated with brown-shelled strains, it has been found to 
occur in Brown Leghorns (a white-shelled breed) and is therefore not linked to egg shell 
colour (Butler et al. 1984).   
FMO3 is the only known enzyme to oxidize TMA (Lang et al. 1998) and 
mutations in FMO3 had been reported to cause fishy-odour syndrome in humans 
(Dolphin et al. 1997a), and consequently it was a strong candidate gene for fishy-egg 
tainting in laying hens.  Honkatukia et al. (2005) mapped fishy-egg tainting and FMO3 
to a region on chicken chromosome 8.  FMO3 contains one 5’ non-coding exon and 
eight coding exons (Figure 2.9).  The causative mutation for fishy-egg taint was found to 
be to be an A to T change at position 984 of the coding sequence, which leads to a 
threonine to serine amino acid substitution at position 329 in the FMO3 enzyme.  The 
mutation will be referred to as FMO3 c.984A>T.  This substitution occurs in the highly 
conserved FATGY amino acid motif (Honkatukia et al. 2005).  The mutation renders the 
FMO3 enzyme unable to oxidize TMA to TMAO, leading to fishy-taint syndrome in 
affected hens (Honkatukia et al. 2005).   
 
 
Figure 2.9 Schematic diagram of FMO3 in Gallus gallus.  The approximate location of 
the c.984 A>T SNP is indicated by the dashed vertical line.  Modified from 
Honkatukia et al. 2005. 
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Honkatukia et al. (2005) found the FMO3c.984A>T mutation in several brown-
shelled breeds of chickens (including three commercial lines, Marans, Green-legged 
partridge, and Transylvanian naked neck).  They speculated that there was a common 
origin for the mutation, likely in the Rhode Island Red breed history.  The authors found 
no differences in FMO3 expression between the genotypes; therefore egg tainting is 
likely caused by decreased biological activity of the enzyme.  Qualitatively, fishy-
smelling phenotype (following dietary challenge with choline chloride) was found to be 
recessively inherited (Honkaukia et al. 2005); however Kretzschmar et al. (2007) found 
a significant difference between the yolk TMA concentrations of AA and AT hens, 
suggesting that egg tainting is quantitatively additive. 
2.4 Objectives and Hypothesis  
The purpose of this thesis was to determine the mode of inheritance of fishy-egg 
tainting in brown-shelled laying hens as well as to examine the effects that different 
sources and levels of choline in the diet have on egg tainting.  We also wanted to 
determine if serum TMA concentration could be used to predict egg-tainting potential. 
Our first hypothesis was that egg tainting is inherited through FMO3 c.984A>T 
and expression is dependent upon inclusion of TMA precursors (i.e. choline) in the diet.  
When hens are fed industry-typical levels of canola meal egg tainting is expressed 
additively.  Secondly, we hypothesized that feeding choline in the form of choline 
chloride would result in lower yolk TMA concentration than choline in the form of 
sinapine because choline chloride is absorbed higher in the digestive tract than choline 
from sinapine. Lastly, we hypothesized that serum TMA concentration is linearly 
correlated to yolk TMA concentration. 
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3 MATERIALS AND METHODS 
3.1 Animal Trials 
Two separate feeding trials, henceforth referred to as the first-generation trial and the 
second-generation trial, were performed at the University of Saskatchewan Poultry 
Centre.  A third experiment was also performed to examine the allelic and genotypic 
ratios of FMO3 c.984A>T in two commercial brown and one white-shelled strains.  The 
experimental protocols for all three trials were approved by the Animal Care Committee 
at the University of Saskatchewan under the animal care protocol number 19940248. 
 
3.1.1 First-Generation Trial 
On April 27th, 2006, 600 one-day-old HyLine Brown chicks were delivered to 
the University of Saskatchewan Poultry Centre.  There were approximately equal 
numbers of male and female chicks.  Upon arrival each chick was fitted with a wing 
band embossed with a unique identification number.  The chicks were dubbed (a portion 
of the comb was removed) and the tissue was collected for DNA extraction. The chicks 
were reared in floor pens under standard conditions and transferred to battery cages 
before the start of lay. 
Prior to the commencement of the feeding trial, 84 hens genotyped for FMO3 
c.984A>T were randomly allocated to individual battery cages.  Approximately 10 hens 
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per genotype were allocated to each of four dietary treatments of varying levels of 
canola meal (Table 3.1).  Only hens of the AT and TT genotypes were included in this 
trial due to an insufficient number of AA hens (only one AA hen was present in the 
population). 
 
Table 3.1 Number of hens allocated to each treatment in the first generation trial. 
 
Diet Genotype 
(% Canola Meal) TT AT 
0 10 9 
6 11 9 
12 10 10 
18 10 15 
Total 41 43 
 
The trial began when the hens were 44 weeks of age.  The hens were fed 
experimental diets for a three-week adaptation period followed by a one-week collection 
period, during which three eggs were collected per hen.  Whole egg and yolk weights 
were recorded and the yolks were analyzed for TMA concentration. 
3.1.1.1 Diets 
The diets used in this trial were control (0% canola meal), 6, 12, and 18% canola 
meal (Table 3.2).  The diets were formulated to meet the requirements outlined by 
HyLine (2006) and NRC (1994), assuming 111 g per hen per day feed consumption.  All 
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diets were formulated to be isocaloric and isonitrogenous (Table 3.3).  Diets were mixed 
at the University of Saskatchewan feed mill. 
 
Table 3.2 Experimental diets for the first-generation trial.  Formulations reported on an 
as-fed basis.  Values are percent of diet on an as-fed basis. 
 
Ingredient  0% CM1 6% CM 12% CM 18% CM 
Wheat 74.85 71.63 68.89 65.91 
Canola Meal 0.00 6.00 12.00 18.00 
Soybean Meal 12.05 8.44 4.82 1.21 
Canola Oil 1.00 1.74 2.48 3.22 
Dicalcium 
Phosphate 
0.73 0.68 0.63 0.58 
Limestone 10.18 10.13 10.09 10.04 
NaCl 0.23 0.23 0.23 0.23 
Choline Chloride 0.10 0.10 0.10 0.10 
Vit/ Min Premix1 0.50 0.50 0.50 0.50 
Wheat Enzyme2 0.05 0.05 0.05 0.05 
DL-Methionine 0.15 0.14 0.12 0.11 
L-Lysine HCL 0.11 0.09 0.07 0.05 
L-Threonine 0.04 0.03 0.01 0.00 
1Supplied per kilogram of diet: vitamin A, 8,000 IU; vitamin D3, 3,000 IU; vitamin E, 25 
IU; menadione, 1.5 mg; riboflavin, 5 mg; pantothenic acid, 8 mg, vitamin B12, 0.012 mg; 
pyridoxine, 1.5 mg; thiamine, 1.5 mg; folic acid, 0.5 mg; niacin, 30 mg; biotin, 0.06 mg; 
iodine, 0.8 mg; copper, 10 mg; iron, 80 mg; selenium, 0.3 mg; manganese, 80 mg; zinc, 
80 mg; quinguard M6S, 0.625 mg, calcium carbonate, 500 mg. 
2Avizyme 1302.  Danisco Animal Nutrition, Malborough, UK. 
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Table 3.3 Calculated nutrient composition of the first-generation diets.  Values are listed 
as percent of diet on an as-fed basis, unless otherwise indicated. 
 
Nutrient 0% CM 6% CM 12% CM 18% CM 
AME1 (kcal/kg) 2.771 2.771 2.771 2.771 
Crude protein 15.50 15.50 15.50 15.50 
Choline 0.122 0.150 0.178 0.207 
Calcium 4.10 4.10 4.10 4.10 
Chloride 0.21 0.21 0.20 0.20 
Non-phytate P2 0.33 0.33 0.33 0.33 
Total P2 0.49 0.52 0.54 0.57 
Potassium 0.71 0.69 0.67 0.65 
Sodium 0.17 0.17 0.17 0.17 
Linoleic acid 1.06 1.18 1.29 1.41 
Arginine 0.93 0.92 0.91 0.90 
Lysine 0.80 0.80 0.80 0.80 
Methionine 0.37 0.37 0.37 0.37 
Met + Cys3 0.61 0.61 0.62 0.62 
Threonine 0.56 0.57 0.58 0.59 
Tryptophan 0.22 0.22 0.23 0.23 
1Apparent metabolizable energy 
2Phosphorous 
3Methionine and cystine 
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3.1.1.2 Statistical Analysis 
The experiment was a two by four factorial design, with genotype as factor 1 and 
diet as factor 2, and individual hens were the experimental unit.  Statistical analysis was 
performed using the mixed procedure of SAS version 9.1 with P<0.05 considered 
significant.  Means were separated using the least significant difference (LSD) method.  
The correlation and regression procedures of SAS were also used to examine the 
relationship between dietary canola meal and yolk TMA level for each of the two 
genotypes.   
Day to day variation in yolk TMA concentration was analyzed by calculating the 
coefficient of variation (CV) between the three eggs analyzed for each hen and then 
analyzing the CVs using the mixed procedure of SAS. 
 
3.1.2 Second-Generation Trial 
Randomly selected heterozygous (AT)  birds from the first generation were 
bred to generate birds of all three genotypes for the second trial.  This was done to 
ensure that sufficient numbers of hens of each genotype were available for use in the 
trial.  A total of 16 roosters were bred to 96 hens via artificial insemination.  Several 
roosters were unable to produce sufficient semen of good quality, and were subsequently 
replaced with TT roosters. 
Hens were inseminated with freshly collected semen once a week for four weeks.  
Eggs were collected daily and stored at 10 ºC until they were incubated.  The eggs were 
candled after 10 days of incubation and transferred to the hatcher on April 31st.  Chicks 
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were hatched, wing banded, dubbed, and placed in floor pens for rearing.  Pullets were 
transferred to battery cages before the start of lay. 
An experiment was designed to investigate the effects of FMO3 c.984A>T 
genotype and choline level and source on egg and serum TMA.  Six hens per genotype 
(AA, AT, and TT) were assigned to one of five dietary treatments consisting of graded 
levels of canola meal.  Additional groups of six TT hens were assigned one of four diets 
containing graded levels of choline chloride.  A total of 114 hens were used.  Only TT 
hens were used for the choline chloride diets because results from the first-generation 
trial showed egg tainting to be recessive, therefore it is unlikely that AA and AT hens 
would show a response to increasing levels of choline chloride. 
Hens were fed the diets ad libitum for a three-week adaptation period and a one-
week collection period. Initial weight, final weight, and egg production were recorded 
for each hen, and feed consumption was recorded for each diet.  Three eggs were 
collected per hen.  On the last day of the trial blood was also collected.  Whole egg and 
yolk weights were recorded.  The yolks and serum were analyzed for TMA 
concentration. 
 
3.1.2.1 Diets 
Commencing at 43 weeks of age, the hens were fed one of nine experimental 
diets for approximately four weeks.  The diets (Table 3.4) consisted of a control (0.130% 
total choline) and four graded levels of choline total (0.158, 0.187, 0.215, and 0.243%) 
each from choline chloride or canola meal, for a total of nine diets.  The choline present 
in the control diet was from the choline naturally found in the soybean meal and wheat 
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present in the diet.  The diets were formulated to meet or exceed HyLine (2006) and 
NRC (1994) requirements assuming 111 g per hen per day feed intake.  All diets were 
formulated to be isocaloric and isonitrogenous.  Diets were mixed at the University of 
Saskatchewan feed lot. 
 
Table 3.4 Dietary formulations for the second-generation trial.  Values reported as 
percent of diet on an as-fed basis. 
 
  Canola Meal (% choline) Choline Chloride (% choline) 
Ingredient 
(%) 
Control 0.158 0.187 0.215 0.243 0.158 0.187 0.215 0.243 
Wheat 69.74 66.79 63.87 60.96 58.03 69.685 69.63 69.575 69.52 
Canola Meal 0.00 6.00 12.00 18.00 24.00 0.00 0.00 0.00 0.00 
Soybean 
Meal 
15.20 11.51 7.81 4.11 0.41 15.20 15.20 15.20 15.20 
Canola Oil 1.76 2.49 3.22 3.95 4.68 1.76 1.76 1.76 1.76 
Celite1 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 
Dicalcium 
Phosphate 
0.71 0.67 0.62 0.57 0.53 0.71 0.71 0.71 0.71 
Limestone 10.17 10.13 10.08 10.03 9.99 10.17 10.17 10.17 10.17 
NaCl 0.24 0.24 0.24 0.23 0.23 0.24 0.24 0.24 0.24 
Choline 
Chloride 
0.00 0.00 0.00 0.00 0.00 0.055 0.11 0.165 0.220 
Vit/Min 
Premix2 
0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 
Wheat 
Enzyme3 
0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
DL-
Methionine 
0.13 0.12 0.11 0.10 0.08 0.13 0.13 0.13 0.13 
1Added as an indigestible marker. 
2Supplied per kilogram of diet: vitamin A, 8,000 IU; vitamin D3, 3,000 IU; vitamin E, 25 IU; menadione, 1.5 mg; 
riboflavin, 5 mg; pantothenic acid, 8 mg, vitamin B12, 0.012 mg; pyridoxine, 1.5 mg; thiamine, 1.5 mg; folic acid, 0.5 
mg; niacin, 30 mg; biotin, 0.06 mg; iodine, 0.8 mg; copper, 10 mg; iron, 80 mg; selenium, 0.3 mg; manganese, 80 mg; 
zinc, 80 mg; quinguard M6S, 0.625 mg, calcium carbonate, 500 mg. 
3Avizyme 1302.  Danisco Animal Nutrition, Malborough, UK. 
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Table 3.5 Calculated nutrient composition of the second-generation diets.  All values are 
reported as percent of the diet on an as-fed basis, unless otherwise noted. 
 
  Canola Meal (% choline) Choline Chloride (% Choline) 
Nutrient Control 0.158 0.187 0.215 0.243 0.158 0.187 0.215 0.243 
AME1 
(kcal/kg) 
2770 2770 2770 2770 2770 2770 2770 2770 2770 
Crude 
protein 
16.20 16.20 16.20 16.20 16.20 16.20 16.20 16.20 16.20 
Choline 0.130 0.158 0.187 0.215 0.243 0.158 0.187 0.215 0.243 
Calcium 4.10 4.10 4.10 4.10 4.10 4.10 4.10 4.10 4.10 
Chloride 0.21 0.21 0.21 0.20 0.20 0.21 0.21 0.21 0.21 
Non-
phytate P2 
0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.33 0.33 
Total P2 0.49 0.52 0.54 0.57 0.60 0.49 0.49 0.49 0.49 
Potassium 0.76 0.74 0.72 0.70 0.68 0.76 0.76 0.76 0.76 
Sodium 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 
Linoleic 
acid 
1.16 1.28 1.39 1.51 1.62 1.17 1.18 1.19 1.12 
Arginine 1.00 0.99 0.98 0.96 0.95 1.00 1.00 1.00 1.00 
Lysine 0.78 0.79 0.81 0.82 0.83 0.78 0.78 0.78 0.78 
Methionine 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 
Met + Cys3 0.61 0.62 0.62 0.63 0.63 0.61 0.61 0.61 0.61 
Threonine 0.55 0.58 0.60 0.63 0.65 0.55 0.55 0.55 0.55 
Tryptophan 0.23 0.24 0.24 0.24 0.24 0.23 0.23 0.23 0.23 
1Apparent metabolizable energy. 
2Phosphorous. 
3Methionine and cystine. 
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3.1.2.2 Statistical Analysis 
A five by three factorial analysis was performed to examine the effects of canola 
meal level and FMO3 c.984A<T genotype on yolk and serum TMA concentration.  
Analysis was performed using the mixed procedure of SAS 9.1.  Significance was set at 
P<0.05 and means were separated using the LSD method.  Regression analyses between 
canola meal level and yolk TMA concentration were performed separately for each 
genotype.  Egg production and average daily gain were analyzed using the same 
procedures as above. 
Day to day variation in yolk TMA concentration was analyzed by calculating the 
coefficient of variation (CV) between the three eggs analyzed for each hen and then 
analyzing the CVs using the mixed procedure of SAS.  The CV was calculated as the 
ratio of the standard deviation to the mean. 
A two by five factorial design was used to analyze the effects of choline source 
and concentration on yolk TMA concentration.  Significance was again set at P<0.05, 
and the LSD procedure was used to separate the means.  Regression analyses were 
performed for each of the choline sources. 
 
3.1.3 Other Layer Strains 
Genotypic frequencies for FMO3 .984A>T were examined in two additional 
brown-shelled and one white-shelled laying strains.  Blood was collected from 100 
Lohmann Brown, ISA Brown, and Lohmann White Leghorn hens.  DNA was extracted 
and the hens were genotyped for the SNP.   
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3.2 DNA Extraction 
Genomic DNA was extracted from comb tissue or blood for genetic analysis. 
 
3.2.1 From Tissue 
At one day of age each chick was dubbed to collect a sample of comb tissue.  
Surgical scissors were used to remove a portion of the comb.  Scissors were dipped in 
ethanol between chicks.  The collected tissue was immediately placed in a 1.5 ml 
microcentrifuge tube containing 300 µl of lysis buffer.  The lysis buffer consisted of 9.4 
mM Tris pH 8, 0.375 M NaCl, 1.9 mM disodium EDTA, and 6.25% SDS.  Samples 
were stored at -20 ˚C until time of extraction. 
Samples were thawed to room temperature and 3 µl of 20 mg/ml proteinase K 
was added.  The tubes were gently inverted several times to mix and incubated overnight 
at 55 ˚C in a shaking water bath.  Samples were cooled to room temperature and 100 µl 
of 4M ammonium acetate was added.  Samples were vortexed at high speed for 
approximately 20 seconds to mix and then centrifuged at 13,900 RMP for 3 minutes. 
The supernatant was transferred to a new 1.5 ml microcentrifuge tube containing 
300 µl of isopropanol.  The tubes were inverted 50 times to mix and then centrifuged for 
3 minutes at 13,900 rpm.  The supernatant was discarded and the tubes air-dried before 
300 µl of 70% ethanol was added.  The tubes were inverted gently several times to wash 
the DNA pellet and then centrifuged for 3 minutes at 13,900 rpm.  The supernatant was 
again removed and the tubes were air-dried before 500 µl of pH 7.4 TE buffer was 
added.  The DNA was allowed to resuspend into solution prior to storage at -20 ˚C. 
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Two modifications were made to the extraction procedure for the second 
generation of chicks.  Firstly, the proteinase K incubation temperature was increased 
from 55 ˚C to 60 ˚C to optimize digestion.  Secondly, the volume of TE buffer used to 
resuspend the DNA pellet was reduced from 500 µl to 100 µl to increase the 
concentration of DNA in the sample. 
 
3.2.2 From Blood 
Samples were collected via brachial veinipuncture into 4 ml EDTA vaccutainer 
tubes and stored at -20 ˚C.  Samples were allowed to thaw overnight at 4 ˚C prior to 
extraction. 
The procedure for extraction was modified from that of Fitzsimmons et al. 
(1998).  Five hundred microlitres of lysis buffer (0.32 M sucrose, 5 mM MgCl2.1% 
Triton X, and 10 mM Tris pH 7.5) was added to 250 µl of blood in a 1.5 ml 
microcentrifuge tube.  The samples were vortexed at high speeds for 10 to 20 seconds 
and then centrifuged at 10,000 rpm for 5 minutes.   
The supernatant was discarded and 500 µl of lysis buffer was added.  The 
samples were vortexed to resuspend the pellet and centrifuged at 10,000 rpm for 5 
minutes.  These steps were repeated twice, after which the supernatant was clear in 
colour. 
The pellet was then resuspended in 500 µl of a PCR extraction buffer.  The 
buffer consisted of 50 mM KCl, 10 mM Tris pH 8.3, 2.5 mM MgCl2, 0.1 mg/ml gelatin, 
0.45% Tween 20, and 0.45% Nonident P40.  Each sample was incubated with 10 µl of 
20 mg/ml proteinase K overnight at 65 ˚C in a shaking water bath.  After incubation 
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some protein residue remained in the bottom of the tubes, so the supernatant was 
transferred to new 1.5 ml microcentrifuge tubes.   
To precipitate the DNA, 50 µl of 3 M sodium acetate was added.  The solution 
was mixed by inversion and approximately 1 ml of 95% ethanol was added.  The 
samples were stored overnight at -20 ˚C and then centrifuged at 13,000 rpm for 15 
minutes.  The supernatant was discarded and 500 µl of 70% ethanol was added.  The 
samples were vortexed briefly and then centrifuged at 13,000 rpm for 10 minutes.  The 
supernatant was again discarded and the remaining DNA pellet was resuspended in 500 
µl of pH 8.0 TE buffer.  The samples were allowed to resuspend at 4 ˚C overnight and 
then stored at -20 ˚C. 
3.3 Genotyping 
All animals were genotyped for FMO3 c.984A>T, reported by Honkatukia et al. 
(2005).  A Polymerase Chain Reaction-Restriction Length Polymorphism (PCR-RFLP) 
was developed with the aid of Sequencher version 4.1 (Genecodes) software and the 
reported genomic FMO3 sequence for Gallus gallus (Genbank accession number 
AH012591). 
The forward and reverse primers (forward: 5’-GCT CAT CAC CCG CTT CTG 
G-3’; reverse: 5’-GCC TCG TTG TTC TTG CTT TCG-3’) were designed using 
OligoAnalyzer version 3.1 (Integrated DNA Technologies) and were obtained from 
Operon Biotechnologies, Inc.  The primers were resuspended in 1 ml of TE buffer (pH 
8.0) and stored at -20 ˚C.  Aliquots were diluted to 10 pmol/µl and stored at 4 ˚C. 
Each PCR reaction consisted of 1 µl of DNA template and 20 µl of PCR cocktail 
(0.2 pmol forward primer, 0.2 pmol reverse primer, 0.2mM dNTP mix (Fermentas), 1X 
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PCR buffer (Fermentas), 1.9 mM MgCl2 (Fermentas), and 0.5 units of Taq polymerase 
(Fermentas) in ultra pure water.  A drop of mineral oil was added to each tube to prevent 
evaporation.  Thermocycling was performed using a Robocycler Gradient 96 
thermocycler (Stratagene).  The reaction began with a two-minute denaturation period at 
94 ˚C.  This was followed by 35 cycles of 50 seconds at 94 ˚C, 50 seconds at 63 ˚C, and 
50 seconds at 72 ˚C.  The last step was four-minute final extension period at 72 ˚C. 
The resulting 462 bp PCR product was then digested with the restriction 
endonuclease BsrI (Fermentas).  Directly added to each reaction product was 10 units of 
BsrI and 2 µl of Buffer B (Fermentas), which was then incubated for 4 hours at 65 ˚C.  
The cleavage sequence for BsrI is ACTGGN|, which subsequently cleaved the A allele 
of the FMO3 c.984A>T SNP but not the T allele.  This resulted in the T allele remaining 
462 bp and the A allele being cleaved into 400 and 62 bp fragments.  The digest 
products were electrophorized on a 2% agarose gel to visualize the differences in 
fragment length  
3.4 Trimethylamine Determination 
The procedures for determination of TMA concentration in serum and egg yolk 
were modified from those reported by Reese et al. (2004). 
 
3.4.1 In Egg Yolk 
Eggs were collected on the day of lay and stored for up to one week at 4 ˚C.  
Whole egg weight was recorded.  The yolk was separated, weighed, and stored in a 50 
ml centrifuge tube at -20 ˚C.  The yolk was thawed and 1 g of 10% trichloracetic acid 
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(TCA) in water was added per gram of yolk to precipitate protein.  The yolk and acid 
were mixed with a metal spatula to homogenize and allowed to sit overnight at room 
temperature. 
The next day the solution was filtered through a folded sheet of 11 cm Whatman 
#2 filter paper.  The filtrate was stored for up to four weeks at 4 ˚C.  A 2 ml aliquot was 
transferred to a 16 X 100 glass culture tube and 1.5 ml of potassium hydroxide (KOH) 
was added to separate trimethylamine from its salts.  The tube was vortexed briefly and 
0.5 ml of neutral buffered formalin (NBF) was added to fix the other nitrogenous 
compounds.  The tube was again briefly vortexed and 5 ml of toluene was added.  A set 
of 40 tubes, capped with polypropylene stoppers, was shaken at 250 rpm in an orbital 
shaker for 2 hours at room temperature.  This allowed the free trimethylamine to move 
from the aqueous phase into the toluene. 
After shaking, a 2.5 ml aliquot of the toluene phase was transferred to a new 16 
X 100 tube and 2.5 ml of 0.02% picric acid in toluene was added.  The picric acid 
formed a yellow picrate complex with the nitrogen of the TMA.  Approximately 1.5 ml 
was transferred to a plastic cuvette and placed in a spectrophotometer and the 
absorbance at 410 nm was recorded.  A standard curve was produced from 14 TMA 
standard solutions (ranging in concentration from 0 to 29.3 µg/ml TMA-nitrogen) to 
calculate the TMA-nitrogen concentration of each yolk sample.  TMA concentration was 
then calculated from the TMA-nitrogen concentration. 
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3.4.2 In Serum 
Blood was collected via brachial veinipuncture into 4 ml vaccutainer serum 
tubes.  The tubes were stored overnight at 4 ˚C to encourage clotting and then 
centrifuged at 3000 rpm for 5 minutes to separate the serum from the clot.  The serum 
was transferred to screw cap microcentrifuge tubes and stored at -20 ˚C until the time of 
analysis. 
Serum was thawed at room temperature.  A 650 µl aliquot of serum was mixed 
with 650 µl of 10% TCA in a 1.5 ml centrifuge tube.  If 650 µl of serum was not 
available the total amount present was used and volumes of the solutions added were 
adjusted accordingly.  The tubes were vortexed and then centrifuged at approximately 
14,000 rpm for 5 minutes.  A 1 ml aliquot of the supernatant added to 750 µl of KOH in 
a 16 X 100 culture tube and vortexed, followed by the addition of 250 µl NBF.  The tube 
was again vortexed and 2.5 ml of toluene was added.  The tube was capped and a set of 
40 tubes was shaken at 250 rpm for 2 hours.  In a plastic cuvette, 500 µl of the toluene 
supernatant was added to 500 µl of 0.02% picric acid in toluene to form a yellow TMA-
nitrogen picrate complex.  The spectrophotometric absorbance at 410 nm was recorded 
and a standard curve was used to calculate the TMA-nitrogen, and subsequently TMA, 
concentration of the serum sample.   
3.5 Feed Analysis 
Dry matter content of each diet was determined using AOAC (1990) method 
930.15.  Crude protein was analyzed using AOAC (1995) method 990.03.   
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3.5.1 Choline Determination 
Free choline concentration was analyzed for each experimental diet was well as 
samples of the soybean meal and canola meal used in the diets.  Extraction was 
performed using the procedures developed by Menten and Pesti (1998).  In a Goldfisch 
beaker, 2 g of finely ground feed ingredient was combined with 25 ml of extractant (0.5 
M KOH in methanol).  Boiling beads were added prior to simmering for 2 hours on a 
Goldfish apparatus.  When the solution had cooled to room temperature 30 ml of 
distilled water was added and the pH was adjusted to 6.0 to 6.5 with HCl.  The solution 
was filtered through one 11 cm sheet of Whatman #2 filter paper into a 100 ml 
volumetric flask and the volume of the filtrate was increased to 100 ml with distilled 
water.  This solution was then used for choline quantification. 
The Choline/Acetylcholine Quantification Kit from BioVision Research Products 
(catalog #K615-100) was used to determine the choline concentration of the filtrate.  
The kit oxidizes free choline to betaine, and this reaction yields products that react with 
the supplied Choline Probe and fluoresce at 587 nm when excited at 535 nm.  Standards 
and samples were prepared in a 96-well microtiter plate.  The standards (50 µl each of 0, 
2, 4, 6, 8, and 10 pmol/µl of choline) were prepared using the choline standard supplied 
in the kit.  Samples were prepared by adding 1 µl of filtrate (from the extraction) to 49 
µl of Choline Assay Buffer (supplied in the kit).   
To each well was added 48 µl of a reaction mix, which consisted of 44 µl of 
Choline Assay Buffer, 2 µl of Choline Probe (dissolved in anhydrous DMSO), and 2 µl 
of Enzyme Mix (dissolved in Choline Assay Buffer).  The fluorescence was read in a 
fluorometer at Ex/Em = 535/590 nm.  The background reading (from the 0 pmol/µl 
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standard) was subtracted from all of the fluorescence readings and a standard curve was 
used to calculate the concentration of choline in the filtrate.  Dilution factors were then 
used to calculate the concentration of free choline in the samples. 
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4 RESULTS 
4.1 First-Generation Trial 
4.1.1 Genotyping 
A representative agarose gel of the FMO3 c.984A>T PCR-RFLP is presented in 
Figure 4.1.  Representative PCR products of each genotype were sequenced by the Plant 
Biotechnology Institute – National Research Council (Saskatoon, Saskatchewan) to 
confirm the accuracy of the test.  A BLAST search  (National Center for Biotechnology 
Information) of the sequence also confirmed that only FMO3 was being amplified.   
 
Figure 4.1 Representative gel for the FMO3 c.984A>T PCR-RFLP.  Lane 1 is a kb1+ 
ladder, lanes 2 and 6 are TT, lanes 3 and 5 are AT, and lanes 4 and 7 are AA 
chickens respectively. 
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The allele frequencies of the first generation were not in Hardy-Weinberg 
equilibrium (Table 4.1).  See Appendix A for individual genotype data 
 
Table 4.1 First-generation genotypic and allelic frequencies for FMO3 c.984A>T, where 
n is the total number of birds per genotype. 
 
Genotype n Frequency 
AA 7 0.01 
AT 473 0.79 
TT 118 0.20 
Allele  Frequency 
A  0.41 
T  0.59 
 
4.1.2 Yolk TMA 
4.1.2.1 Genotype and Canola Meal 
Genotype, diet, and their interaction all had highly significant effects on yolk 
TMA concentration (Table 4.2, Figure 4.2).  See Appendix B for individual yolk TMA 
concentrations.  The mean TMA concentration of the three eggs collected was used for 
statistical analysis.  Hens of the AT genotype did not demonstrate a response in yolk 
TMA concentration to increasing levels of canola meal.  In contrast, there was a 
significant linear regression between canola meal level and yolk TMA concentration for 
hens of the TT genotype ( 
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Table 4.3).  The regression equation for the TT genotype is TMA = 0.304CM + 
2.703, therefore the calculated maximum inclusion level of CM (to produce a yolk TMA 
concentration of 4 µg/g) is 4%. 
 
Table 4.2 Results of the test of main effects on yolk TMA concentration in the first-
generation trial. 
 
Main Effect P Value 
Genotype <0.0001 
Diet <0.0001 
Interaction <0.0001 
 
 
Table 4.3 Results of the linear regression analysis between yolk TMA concentration 
(µg/g) and canola meal (%) in the first-generation trial, separated by 
genotype. 
 
Genotype P Value R2 Value 
AT 0.3371 0.0243 
TT <0.0001 0.5149 
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Figure 4.2 The effects of genotype and diet (% canola meal) on yolk TMA concentration 
(µg/g) in the first-generation trial.  The dashed line represents the regression 
equation for the TT genotype.  Means with the same letter are not 
significantly different (P<0.05).  Error bars indicate the standard error of the 
mean. 
 
4.1.2.2 Variation 
A coefficient of variation (CV) was calculated for each hen using the yolk TMA 
concentrations from the three eggs collected (see Appendix B for individual CVs).  Only 
genotype had a significant effect on the CV (Table 4.4).  There was significantly greater 
day-to-day variation in yolk TMA concentration for AT hens than for TT hens (Table 
4.5).   
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Table 4.4 The main effects of genotype, diet, and their interaction on the CV of yolk 
TMA concentration. 
 
Main Effect P Value 
Genotype 0.0039 
Diet 0.0934 
Interaction 0.1999 
 
Table 4.5 Coefficient of variation of individual yolk TMA concentration as separated by 
FMO3 c.984A>T genotype. 
 
Genotype AT TT 
Coefficient of Variation 48.52A 34.27B 
SEM 3.43 3.32 
ABMeans in the same row that do not share a common superscript are significantly 
different (P<0.05).  SEM=standard error of the mean. 
 
4.2 Second-Generation Trial: Genotype and Canola Meal Level 
In this section, the results of the FMO3 genotype (AA, AT, or TT) by canola 
meal level (0, 6, 12, 18, or 24%) trial are presented.  The results of the choline chloride 
diets are presented in section 4.3.   
 
4.2.1 Genotyping 
The genotypic ratios in the second generation differ slightly from the expected 
1:2:1 ratio of heterozygote to heterozygote mating because three AT roosters were 
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replaced by TT roosters because of poor sperm quality (Table 4.6).  See Appendix C for 
individual genotypes.  
 
Table 4.6 Second-generation genotypic and allelic frequencies for FMO3 c.984A>T, 
where n is the total number of birds per genotype. 
 
Genotype n Frequency 
AA 163 0.20 
AT 398 0.50 
TT 241 0.30 
Allele  Frequency 
A  0.45 
T  0.55 
 
4.2.2 Yolk TMA 
4.2.2.1 Genotype and Canola Meal 
The effects of genotype, diet, and their interaction on yolk TMA concentration 
were all significant (Table 4.7).  There was no significant response in yolk TMA 
concentration from hens of the AA and AT genotypes with increasing levels of canola 
meal (Figure 4.3).  Additionally, there was no significant difference between the yolk 
TMA concentrations of eggs from hens of the AA and AT genotypes at any of the levels 
of canola meal.  See Appendix D for individual yolk TMA concentrations.   
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A significant linear regression was found between yolk TMA concentration and 
canola meal level for hens of the TT genotype (Table 4.8).  The regression equation for 
the TT genotype is TMA = 0.186CM + 2.613, therefore the calculated CM inclusion 
level to obtain 4 µg/g yolk TMA is 7%. 
 
Table 4.7 The main effects of genotype, diet, and their interaction on yolk TMA 
concentration in the second-generation trial. 
 
Main Effect P Value 
Genotype <0.0001 
Diet 0.0019 
Interaction 0.0273 
 
Table 4.8 Regression analysis by genotype between yolk TMA concentration and CM 
inclusion level. 
 
Genotype P Value R2 Value 
AA 0.6385 0.0080 
TT 0.4414 0.0248 
AT 0.0005 0.3599 
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Figure 4.3 The effects of FMO3 c.984A>T genotype and canola meal on yolk TMA 
concentration (µg/g) in the second-generation trial.  The dashed line 
represents the regression equation of the TT genotype.  Means with the same 
letter are not significantly different (P<0.05).  Error bars indicate the standard 
error of the mean. 
 
4.2.2.2 Variation 
Neither diet, genotype, nor their interaction had significant effects on the CV for 
yolk TMA concentration (Table 4.9).  However, the effect of genotype approached 
significance, with the AT genotype again demonstrating the highest CV (Table 4.10).  
See Appendix D for individual CVs.   
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Table 4.9 The main effects of genotype, diet, and their interaction on the coefficient of 
variation of yolk TMA concentration in the second-generation trial. 
 
Main Effect P Value 
Genotype 0.0873 
Diet 0.3311 
Interaction 0.1824 
 
 
Table 4.10 Coefficient of variation of yolk TMA concentration by genotype in the 
second-generation trial, where SEM is the standard error of the mean. 
 
Genotype AA AT TT 
Coefficient of 
Variation 
41.75 56.26 45.15 
SEM 4.71 4.81 4.81 
 
4.2.3 Serum TMA 
4.2.3.1 Genotype and Diet 
Diet alone did not have a significant effect on serum TMA concentration, 
however genotype and diet by genotype interaction did (Table 4.11).  No clear trend was 
apparent when the means were separated using the LSD method (Figure 4.4).  No 
significant differences were found within the AA and AT genotypes and only the 0% 
CM diet was significantly different for the TT genotype.  Significant differences within 
diets were only found for the 12 and 18% CM diets.  No significant linear regressions 
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were found between serum TMA concentration and diet for any of the genotypes (Table 
4.12).  See Appendix D for individual serum TMA concentrations. 
 
Table 4.11 The main effects of genotype, diet, and their interaction on serum TMA 
concentration in the second-generation trial. 
 
Main Effect P Value 
Genotype 0.0208 
Diet 0.6829 
Interaction 0.0044 
 
Table 4.12 Regression, by genotype, between serum TMA concentration and canola 
meal inclusion level in the second-generation trial. 
 
Genotype P Value R2 Value 
AA 0.5024 0.0190 
AT 0.6530 0.0080 
TT 0.0682 0.1268 
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Figure 4.4 The effects of genotype and diet (% canola meal) on serum TMA 
concentration (µg/ml) in the second-generation trial.  Means with the same 
letter are not significantly different (P<0.05).  Error bars indicate the standard 
error of the mean. 
 
4.2.3.2 Correlation With Yolk TMA 
No correlation was found between yolk and serum TMA concentration (Table 
4.13). 
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Table 4.13 Correlation between yolk and serum TMA concentrations, both overall and 
separated by genotype. 
 
Genotype P value r Value 
AA 0.4840 -0.1436 
AT 0.6512 0.0951 
TT 0.5889 -0.1088 
Overall 0.3817 0.1044 
 
 
4.2.4 Production Characteristics 
Rate of lay and average daily gain (ADG) were analyzed to observe if FMO3 
c.984A>T genotype affects production characteristics. ADG was calculated as the final 
body weight minus the initial body weight divided by the number of days on trial.  Rate 
of lay was calculated as the total number of eggs laid divided by the hen days (number 
of days for which egg production was recorded).  Only the total feed consumed per diet 
was recorded (Table 4.14), therefore statistical analyses could not be performed.  
Average daily intake (ADI) was calculated as the total feed consumed divided by the 
total hen days for that treatment.  See Appendix E for individual egg production and 
body weights. 
It should be noted that the short duration of this trial (four weeks) does not 
provide information about the whole production curve, but does provide enough 
information to determine if a more detailed production study was warranted.  Diet and 
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genotype did not have significant effects on egg production or ADG (Table 4.15), and 
therefore a full-scale production trial was not performed. 
 
Table 4.14 Total feed consumption and average daily intake (ADI) for each diet in the 
second-generation trial. 
 
Diet ADI (g/bird/day) 
0% CM 102 
6% CM 103 
12% CM 105 
18% CM 99 
24% CM 104 
0.055% ChCl 104 
0.11% ChCl 98 
0.165% ChCl 99 
0.22% ChCl 108 
 
Table 4.15 The main effects of genotype, diet, and their interaction on average daily gain 
(ADG) and egg production in the second-generation trial. 
 
 P Value 
Main Effect ADG Egg Production 
Genotype 0.3517 0.6027 
Diet 0.2525 0.0915 
Interaction 0.5688 0.4773 
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4.3 Second-Generation Trial: Choline Source and Level 
The results of the choline chloride and canola meal diets for hens of the TT 
genotype are presented in this section.  The canola meal diets were the same as those 
presented in section 4.2; though in this section they will be referred to by their total 
choline concentration (0.158, 0.187, 0.215, and 0.243%).  The control diet (0.130%) was 
used for both choline sources.  It was fed to only one group of TT hens, and was 
therefore treated as a pseudo-replicate. 
 
4.3.1 Yolk TMA 
The effects of choline source, level, and their interaction on yolk TMA 
concentration were all found to be significant (Table 4.16).  There appeared to be no 
response in yolk TMA concentration to increasing levels of choline chloride; in fact only 
the 0.187 and 0.243% diets were significantly different (Figure 4.5).  In contrast, there 
was a significant linear regression between choline level and yolk TMA concentration 
for the canola meal diets (Table 4.17).  The regression equation for CM is 
TMA = 39.411(% choline) – 2.513.  See Appendix D for individual yolk TMA 
concentrations. 
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Table 4.16 The main effects of choline source, level, and their interaction on yolk TMA 
concentration. 
 
Main Effect P Value 
Source 0.0002 
Level 0.0110 
Interaction 0.0196 
 
 
Table 4.17 Regression, by choline source, between yolk TMA concentration and choline 
inclusion level. 
 
Choline Source P Value R2 Value 
Canola Meal 0.0004 0.3608 
Choline Chloride 0.7023 0.0053 
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Figure 4.5 The effects of choline source (canola meal or choline chloride) and level on 
yolk TMA concentration (µg/g) of TT hens in the second-generation trial.  
The light grey bars represent the canola meal (CM) diets, and the dark grey 
bars the choline chloride (ChCl) diets.  The white bar represents the control 
diet (0% CM and 0% ChCl), which was pseudo-replicated.  The dashed line 
represents the regression equation for the CM diets.  Means with the same 
letter are not significantly different (P<0.05).  Error bars indicate the standard 
error of the mean. 
 
4.4 Other Layer Strains 
A summary of the genotypic and allelic frequencies of a one white-shelled laying 
strain (Lohmann White Leghorn) two commercial brown-shelled (Lohmann Brown and 
ISA Brown) and is presented in Table 4.18, with individual genotypes presented in 
Appendix G.   
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Table 4.18 Genotypic and allelic frequencies of FMO3 c.984A>T for two commercial 
brown-shelled and one commercial white-shelled laying strains, with n as the 
total number of hens per genotype per strain and WLH as White Leghorn. 
 
 Lohmann Brown ISA Brown Lohmann WLH 
Genotype n Frequency n Frequency n Frequency 
AA 45 0.45 41 0.44 89 1.00 
AT 54 0.54 39 0.42 0 0.00 
TT 1 0.01 13 0.14 0 0.00 
A  0.72  0.65  1.00 
T  0.28  0.35  0.00 
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5 DISCUSSION 
5.1 Allelic and Genotypic Frequencies 
The allele frequencies of the first-generation population (Table 4.1) were not in 
Hardy-Weinberg equilibrium (HWE).  This was due to the fact that a three-way cross 
mating design had been used to produce the first-generation population.  Three pure 
lines are maintained by the breeding company; two of these lines were crossed to 
produce the hens that were then mated to the third line to produce commercial chicks.  
The low frequency of the AA genotype (0.01) suggests that the male line was almost 
fixed for the T allele. The Lohmann hens (Table 4.18) also did not fit HWE.  This was 
expected, as Lohmann International is using selective breeding to eliminate the TT 
genotype from its commercial strains and therefore mating was not random (Lohmann 
Tierzucht 2005).  Lohmann has been very successful in eliminating the T allele from 
their commercial brown line, as the frequency of the T allele has decreased from 0.62 
(Honkatukia et al. 2005) to 0.28 (Table 4.18) in only a few years.  In contrast, the allele 
frequencies of the ISA brown hens (Table 4.18) did fit HWE, indicating that ISA was 
likely not selecting for FMO3 in that generation. 
5.2 Inheritance of Fishy-Egg Taint 
The human detection threshold of TMA in whole-egg homogenate has been 
estimated to be 1 µg/g (Griffiths et al. 1979).  Given that TMA is almost exclusively 
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concentrated in the yolk (Hobson-Frohock et al. 1973) and that the yolk makes up 
approximately 25% of the mass of the total egg contents (Suk and Park 2001), the 
human detection threshold can be estimated to be 4 µg/g in the yolk.  However, there is 
variability in the ability of individuals to detect TMA (Griffiths et al. 1979), and while 4 
µg/g is an appropriate benchmark, eggs with yolk TMA concentrations above that are 
likely to be undetected by the majority of consumers.   
Our results showed that when hens were fed diets containing canola meal, 
including and exceeding those typically found in commercial egg production (Hickling 
2001), egg tainting was inherited as a recessive trait.  Only hens of the TT genotype 
displayed a significant increase in yolk TMA with increasing levels of canola meal 
(Figure 4.3).  Also, there was no significant difference between the AA or AT genotypes 
for any of the diets, confirming that egg tainting is indeed recessive and not additive at 
these levels of dietary substrate inclusion.  These findings are consistent with the 
recessive inheritance of trimethylaminuria (accumulation of TMA) in humans and dairy 
cows (Dolphin et al. 1997a, Lundén et al. 2002b). 
Our data did not support our original hypothesis that fishy egg tainting was 
additive.  We hypothesized that the heterozygous hens would be able to metabolize 
TMA to a limited extent to prevent a detectible odour in the eggs (TMA yolk 
concentration less than 4 µg/g) but that the yolk TMA concentration would still be 
higher than that of the homozygous normal hens. 
It is likely that the diets used in our trials resulted in low enough TMA 
production that, in the heterozygous hens, there was sufficient wild-type FMO3 to 
metabolize the TMA present, but at higher levels of TMA generation the oxidative 
capabilities of the wild-type FMO3 would become saturated, resulting in excessive 
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accumulation of TMA in developing follicles.  Therefore under commercial production 
practices (i.e. canola meal content less than 24%), TMA generation is sufficiently low 
enough that egg tainting is recessive. 
5.3 Choline Source 
Choline is an essential nutrient for laying hens.  Deficiency can lead to perosis in 
chicks (slipped Achilles tendon) and increased liver weight (Budowski et al. 1977).  
Unlike chicks, hens are able to synthesize a large portion of their choline requirements 
(Crawford et al. 1969).  The NRC (1994) choline requirements for brown-shelled layers 
are 0.1225% for chicks, 0.047% for pre-lay pullets, and 0.1050% for laying hens.  
HyLine (2006) recommends supplementing all grower rations with 0.03% and layer 
rations with 0.02% additional choline to ensure requirements are met.  All of our 
experimental diets (Table 3.2, Table 3.4) exceeded NRC (1994) choline requirements.  
Even the second-generation control diet, which was not supplemented with choline 
chloride, contained 0.130% total choline.  This raises the question as to whether laying 
hen diets really need to be supplemented with choline.  Decreasing or even eliminating 
choline chloride from laying hen diets may allow canola meal to be fed to TT hens at 
low levels (i.e. 5%) without leading to the production of tainted eggs. 
Our results are the first to confirm that genotypically predisposed (FMO3 c. 984 
TT) hens do not produce fishy-tainted eggs when fed choline chloride at levels up to 
0.220% (Figure 4.5).  This confirms the results of Goh et al. (1979b), who reported that 
when taint-producing hens were fed 0.05% choline chloride no tainted eggs were 
produced, but when the same hens were fed 0.14% sinapine bisulphate (the equivalent of 
10% RSM) tainted eggs were produced.  Budowski et al. (1977) found that when 
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0.101% choline chloride (in a casein-glucose diet) was fed to 30-day old chicks over 
90% was absorbed by the duodenum and upper jejunum.  This leaves very little, if any, 
choline available for fermentation to TMA by bacteria located in the ceca (Emmanuel et 
al. 1984). 
As previously stated, Honkatukia et al. (2005) and Kretzschmar et al. (2007) 
were able to induce egg tainting in TT hens by feeding high concentrations of choline 
chloride (0.60% total choline).  Choline is transported across the intestinal brush-boarder 
membrane via facilitated diffusion, a mechanism that can become saturated (Hegazy and 
Schwenk 1984, Saitoh et al. 1992).  It is possible that the very high level of inclusion 
used by Honkatukia et al. (2005) and Kretzschmar et al. (2007) overwhelmed the 
absorptive mechanisms in the distal small intestine, allowing more choline chloride to 
reach, and thus be utilized by, TMA-producing bacteria.  
5.4 Serum Versus Yolk Trimethylamine Concentration 
Serum TMA concentration was not predictive of yolk TMA concentration.  It 
would have been advantageous if serum and egg TMA concentrations were correlated.  
This would have enabled both male and female chickens of any age to be evaluated for 
tainting potential, saving time and resources.  The ability to evaluate the tainting 
potential of males would have been useful in pedigree analysis and selective breeding 
programs.  However, with modern molecular techniques and knowledge of the 
inheritance pattern under commercial conditions, it is simpler and faster to select against 
tainting by genotyping for FMO3 c.984A>T rather than yolk TMA analysis. 
There are several explanations as to why we did not observe a linear correlation 
between yolk and serum TMA concentrations.  Serum TMA concentration only provides 
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a momentary snap-shot of the TMA profile of an animal, where as yolk TMA shows a 
longer-term profile.  Though the rate of TMA oxidation varied significantly between 
tainting and non-tainting hens, Pearson et al. (1979) found that 24 hours after 
intravenous administration of 14C-TMA there was no significant difference in 14C-TMA 
concentration remaining in circulation.  Given the short half-life of TMA in circulation, 
for both tainting and non-tainting hens, time of blood sampling may have had a major 
impact on our results.   
Blood sampling was not performed randomly; we began sampling at 
approximately 8:30 a.m. and obtained samples from each hen belonging to one treatment 
before moving on to the next.  Sample collection took approximately 5 hours to 
complete.  The 24% CM group was the second to be sampled and the 18%CM group 
was the last, leading us to believe that time of sampling may be responsible for the 
unexpectedly low serum TMA concentration found in the 24% CM group.  The lights in 
the barn went on automatically at 4:00 a.m. and the hens always had continuous access 
to feed, therefore it is unlikely the unexpected serum TMA results were a result of 
differences in gut fill between the first and last birds sampled.  It is still possible, 
however, that there may be diurnal variations in serum TMA concentration.  The rapid 
phase of yolk development occurs over a period of 6 to 14 days (Marza and Marza 
1935); therefore the diurnal variations in circulating TMA levels are unlikely to affect 
yolk TMA concentrations. 
5.5 Day-to-Day Yolk Trimethylamine Variation 
Our findings of large day-to-day variations in yolk TMA concentration are 
supported by previous reports in the literature.  Vondell (1932) was the first to note that 
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tainted eggs were only laid intermittently by some hens, with individual hens displaying 
large day-to-day variation in the “smelliness” of their eggs.  Bolton et al. (1976) also 
noted great variation in egg tainting.  They found that only approximately one out of 
every five eggs laid by tainting hens was tainted.   
It was somewhat surprising to find greater individual variation amongst the AT 
than the TT hens.  However, upon further consideration, this pattern can be explained.  
The CV for each hen was calculated by dividing the standard deviation of the TMA 
concentration of the three yolks by there mean.  If a TT hen and an AT hen, for example, 
had the same standard deviation but the TT hen had a higher mean the AT hen would 
have a greater CV. 
Another explanation is that the AA hens, with two functional copies of FMO3, 
are fully capable of metabolizing circulating TMA and therefore display the lowest 
variation of the three genotypes (Table 4.10).  The TT hens can only metabolize very 
little, if any, TMA (Pearson et al. 1979, Honkatukia et al. 2005).  Therefore the primary 
factor influencing yolk TMA concentration is absorption of TMA from the gut.  The AT 
hens, with only one functional copy of FMO3, are still able to metabolize TMA, but to a 
lesser extent that the AA hens (Kretzschmar et al. 2007).  It can be assumed that, as 
such, they are more sensitive to factors that inhibit the oxidative capacity of FMO3, such 
as glucosinolates.  The yolk TMA concentration of AT hens is influenced not only by 
the amount of TMA absorbed by the gut but also by factors which inhibit FMO3, 
therefore resulting in greater variation than either AA or TT hens. 
The cause of the variation in yolk TMA concentration is still unclear.  Marza and 
Marza (1935) reported day-to-day fluctuations in the rate of yolk growth during the 
rapid phase of yolk development.  It is possible that such variations in yolk growth may 
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impact TMA accretion in the yolk, resulting in inter-yolk variation in TMA 
concentration. 
There are some differences between the results of the first and second-generation 
trials.  While both trials display the same trends, the yolk TMA concentrations are 
generally lower in the second-generation trial for the corresponding genotype and canola 
meal level (Figure 4.2, Figure 4.3).  This may be due in part to differences in diet 
formulation, gut microbiota, and other unknown factors that influence yolk TMA 
variability.   
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6 CONCLUSIONS 
The purpose of this study was to determine the mode of inheritance of fishy-egg 
tainting when brown-shelled hens are fed diets containing canola meal at commercial 
levels of inclusion.  We have definitively shown that egg tainting is recessively inherited 
when hens are fed canola meal up to levels of 24%.  There is no “safe” level of canola 
meal that can be fed to affected hens without the risk of egg tainting; however, low 
levels (such as 6%) may be used if the producer is willing to accept the risk that a small 
portion of the eggs will be tainted.  Also, we have found that choline chloride, at and 
slightly above levels typical to commercial production, does not cause fishy-egg 
tainting. 
With the availability of molecular testing, and the inheritance pattern now clear, 
breeding companies will be able to remove tainting from their flocks.  The recessive 
nature of the trait is advantageous to primary breeding companies, as they will only need 
to select against the T allele in one, rather than both, of their parental lines.  If the 
parental line to be selected against is a production of two pure grandparent lines (which 
is likely to be the case as commercial laying hen lines are often the product of a three or 
four-way cross) then the T allele must be removed from both grandparental lines. 
The elimination of tainting hens from commercial lines will allow brown-shelled 
egg producers to feed canola meal, an economical feed ingredient, without worry of 
producing tainted eggs.  This will expand export markets for Canadian canola meal to 
brown-shelled egg producers around the world. 
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Large day-to-day variations in yolk TMA concentration are present in hens of all 
three genotypes.  The cause of this variation is still unclear, and further research is 
required.  It may be of interest to examine changes in the cecal microbiota over time and 
perhaps factors that may influence choline absorption or yolk deposition.  As well, 
infusions of C14 labeled TMA could be utilized to examine how TMA accumulates  
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APPENDIX A 
First-generation Genotypes 
Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
201 1840 AT  236 1891 AT 
202 1810 AT  237 1829 AT 
203 1871 AT  238 1894 AT 
204 1895 AT  239 1859 AT 
205 1811 AT  240 1846 AT 
206 1834 AT  241 1803 TT 
207 1861 TT  242 1848 AT 
208 1866 AT  243 1844 AT 
209 1862 AT  244 1851 TT 
210 1880 AT  245 1812 AT 
211 1804 AT  246 1825 AT 
212 1872 AT  247 1896 AT 
213 1805 -  248 1826 AT 
214 1806 AT  249 1889 TT 
215 1817 AT  250 1870 TT 
216 1863 AT  251 1836 AT 
217 1858 AT  252 1824 AT 
218 1898 AT  253 1835 AT 
219 1855 TT  254 1892 AT 
220 1842 AT  255 1869 AT 
221 1854 AT  256 1830 AT 
222 1815 AT  257 1832 AT 
223 1801 AT  258 1822 AT 
224 1886 TT  259 1881 AT 
225 1888 AT  260 1841 AT 
226 1802 AT  261 1831 AT 
227 1900 AT  262 1899 TT 
228 1850 AT  263 1847 AT 
229 1856 AT  264 1816 AT 
230 1843 TT  265 1867 AT 
231 1813 TT  266 1883 TT 
232 1897 AT  267 1818 AT 
233 1833 TT  268 1885 AT 
234 1853 TT  269 1887 AT 
235 1808 AT  270 1882 AT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
275 1857 AT  318 1931 AT 
276 1868 AT  319 1978 TT 
277 1860 AT  320 1982 AT 
278 1865 AT  321 1963 TT 
279 1873 AT  322 1967 AT 
280 1814 AT  323 1952 TT 
281 1875 AT  324 1916 AA 
282 1807 TT  325 1901 AT 
283 1879 TT  326 1940 AT 
284 1839 AT  327 1924 AT 
285 1852 AT  328 1905 AT 
286 1884 AT  329 1902 AT 
287 1877 AT  330 1987 AT 
288 1823 AT  331 1953 AT 
289 1864 AT  332 1939 AT 
290 1849 TT  333 1992 AT 
291 1827 AT  334 1980 AT 
292 1893 AT  335 1933 AA 
293 1837 AT  336 1936 TT 
294 1819 TT  337 1964 AT 
295 1820 AT  338 1903 TT 
296 1828 AT  339 1981 AT 
297 1838 AT  340 1935 TT 
298 1809 AT  341 1956 TT 
299 1878 AT  342 1979 AT 
300 1845 AT  343 1918 AT 
301 1993 AT  344 1910 TT 
302 1938 AT  345 1906 AT 
303 1944 TT  346 1998 AT 
304 1942 AT  347 1986 AT 
305 1965 AT  348 1943 AT 
306 1989 AT  349 1974 TT 
307 1922 AT  350 1976 AT 
308 1975 AT  351 1962 AT 
309 1925 AT  352 1904 AT 
310 1934 AA  353 1917 AT 
311 1914 AT  354 1977 AT 
312 1991 AT  355 1973 AA 
313 1941 AT  356 1949 TT 
314 1970 AT  357 1945 TT 
315 1937 AT  358 1929 TT 
316 1960 AT  359 1969 TT 
317 1988 AT  360 2000 AT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
361 1999 AT  404 2044 TT 
362 1928 AT  405 2086 TT 
363 1911 AT  406 2048 AT 
364 1913 AT  407 2017 TT 
365 1966 AT  408 2005 AT 
366 1959 TT  409 2001 AT 
367 1983 AT  410 2003 TT 
368 1950 TT  411 2079 AT 
369 1951 TT  412 2019 AT 
370 1915 AT  413 2057 AT 
371 1907 TT  414 2008 AT 
372 1955 AT  415 2033 AT 
373 1994 AT  416 2070 TT 
374 1919 TT  417 2027 AA 
375 1971 AT  418 2037 AT 
376 1957 TT  419 2072 TT 
377 1958 TT  420 2084 AT 
378 1995 AT  421 2023 TT 
379 1923 AT  422 2028 AT 
380 1908 TT  423 2083 AT 
381 1912 AT  424 2095 AT 
382 1909 AT  425 2036 AT 
383 1930 AT  426 2075 AT 
384 1946 AT  427 2025 AT 
385 1948 AT  428 2006 AT 
386 1972 AT  429 2094 AT 
387 1984 AT  430 2050 AT 
388 1954 AT  431 2042 TT 
389 1996 AT  432 2043 AT 
390 1921 AT  433 2002 AT 
391 1927 AT  434 2026 AT 
392 1947 AT  435 2069 AT 
393 1932 AT  436 2047 AT 
394 1920 AT  437 2004 AT 
395 1926 AT  438 2093 AT 
396 1961 AT  439 2011 AT 
397 1997 AT  440 2039 AT 
398 1968 AT  441 2021 TT 
399 1990 AT  442 2022 AT 
400 1985 AT  443 2085 AT 
401 2100 TT  444 2012 AT 
402 2091 AT  445 2078 AT 
403 2034 AT  446 2010 AT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
447 2015 TT  490 2059 AT 
448 2013 AT  491 2041 AT 
449 2089 AT  492 2073 AT 
450 2096 TT  493 2062 AT 
451 2088 AT  494 2074 TT 
452 2007 AT  495 2046 AT 
453 2018 AT  496 2020 AT 
454 2067 TT  497 2055 TT 
455 2080 AT  498 2077 AT 
456 2092 AT  499 2052 AT 
457 2061 AT  500 2053 TT 
458 2031 AT  501 2186 AT 
459 2014 TT  502 2156 AA 
460 2076 AT  503 2178 TT 
461 2045 AT  504 2162 TT 
462 2040 AT  505 2164 TT 
463 2030 AT  506 2190 AT 
464 2060 TT  507 2115 AT 
465 2087 AT  508 2143 AT 
466 2090 TT  509 2102 AT 
467 2081 AT  510 2145 AT 
468 2038 AT  511 2153 AT 
469 2029 AT  512 2188 AT 
470 2058 AT  513 2169 AT 
471 2032 AT  514 2187 AT 
472 2066 TT  515 2127 TT 
473 2009 AT  516 2147 AT 
474 2056 AT  517 2146 AT 
475 2064 AT  518 2130 AT 
476 2082 AT  519 2113 AT 
477 2016 AT  520 2131 AT 
478 2098 AT  521 2166 AT 
479 2051 AT  522 2120 TT 
480 2097 AT  523 2149 AT 
481 2035 AT  524 2109 AT 
482 2049 AT  525 2175 AT 
483 2063 AT  526 2180 AT 
484 2068 AT  527 2106 AT 
485 2065 AT  528 2139 AT 
486 2054 AT  529 2150 TT 
487 2024 AT  530 2198 AT 
488 2071 TT  531 2110 AT 
489 2099 TT  532 2121 AT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
533 2129 TT  576 2118 AT  
534 2116 TT  577 2126 AT 
535 2195 AT  578 2184 AT 
536 2107 AT  579 2177 TT 
537 2189 AT  580 2182 AT 
538 2201 AT  581 2167 AA 
539 2158 AT  582 2104 AT 
540 2117 AT  583 2179 AT 
541 2192 TT  584 2148 AT 
542 2124 AT  585 2165 AT 
543 2108 AT  586 2163 AT 
544 2191 AT  587 2132 AT 
545 2103 AT  588 2160 TT 
546 2171 AT  589 2134 AT 
547 2135 AT  590 2111 TT 
548 2122 TT  591 2159 AT 
549 2128 AT  592 2168 AT 
550 2105 AT  593 2101 AT 
551 2161 AT  594 2123 AT 
552 2155 TT  595 2137 AT 
553 2183 AT  596 2193 AT 
554 2119 AT  597 2197 AT 
555 2181 TT  598 2157 AT 
556 2144 AT  599 2200 AT 
557 2151 AT  600 2112 AT 
558 2185 AT  601 2267 AT 
559 2114 AT  602 2203 AT 
560 2174 TT  603 2211 AT 
561 2138 AT  604 2292 AT 
562 2141 AT  605 2216 AT 
563 2196 AT  606 2245 AT 
564 2176 TT  607 2273 AT 
565 2152 AT  608 2208 AT 
566 2199 AT  609 2232 AT 
567 2172 AT  610 2253 TT 
568 2140 AT  611 2244 TT 
569 2136 AT  612 2230 AT 
570 2133 AT  613 2254 AT 
571 2142 TT  614 2231 AT 
572 2173 AT  615 2288 AT 
573 2194 AT  616 2281 AT 
574 2154 AT  617 2215 AT 
575 2125 AT  618 2261 AT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
619 2243 TT  662 2282 AT 
620 2252 AT  663 2275 AT 
621 2294 AT  664 2222 AT 
622 2285 AT  665 2276 AT 
623 2299 AT  666 2286 AT 
624 2260 TT  667 2217 AT 
625 2227 AT  668 2235 AT 
626 2293 TT  669 2213 TT 
627 2263 AT  670 2271 AT 
628 2298 AT  671 2238 AT 
629 2246 AT  672 2247 AT 
630 2204 AT  673 2205 AT 
631 2218 TT  674 2265 AT 
632 2269 AT  675 2264 AT 
633 2284 AT  676 2238 TT 
634 2287 AT  677 2221 AT 
635 2297 AT  678 2249 AT 
636 2226 AT  679 2268 AT 
637 2257 TT  680 2239 AT 
638 2240 TT  681 2234 AT 
639 2251 AT  682 2296 TT 
640 2278 AT  683 2229 AT 
641 2258 -  684 2274 TT 
642 2279 -  685 2237 AT 
643 2250 AT  686 2262 AT 
644 2266 AT  687 2255 AT 
645 2233 AT  688 2295 AT 
646 2289 AT  689 2202 AT 
647 2209 AT  690 2220 AT 
648 2248 AT  691 2206 TT 
649 2241 AT  692 2219 AT 
650 2207 TT  693 2277 AT 
651 2280 AT  694 2224 AT 
652 2259 AT  695 2256 AT 
653 2291 AT  696 2212 AT 
654 2300 AT  697 2225 AT 
655 2236 TT  698 2210 AT 
656 2223 AT  699 2290 AT 
657 2270 TT  700 2242 AT 
658 2301 AT  701 2326 AT 
659 2272 AT  702 2370 TT 
660 2214 AT  703 2324 TT 
661 2283 AT  704 2307 TT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
705 2305 AT  748 2372 AT 
706 2361 AT  749 2332 AT 
707 2360 AT  750 2313 AT 
708 2386 AT  751 2321 AT 
709 2381 TT  752 2379 AT 
710 2317 AT  753 2359 AT 
711 2364 AT  754 2377 TT 
712 2333 AT  755 2330 AT 
713 2392 AT  756 2382 AT 
714 2344 TT  757 2345 AT 
715 2385 TT  758 1744 AT 
716 2334 AT  759 2322 AT 
717 2390 AT  760 2362 AT 
718 2349 AT  761 2389 AT 
719 2319 AT  762 2338 AT 
720 2337 AT  763 2384 AT 
721 2387 AT  764 2368 TT 
722 2369 AT  765 2306 TT 
723 2314 TT  766 2400 TT 
724 2394 AT  767 2388 AT 
725 2325 AT  768 2380 AT 
726 2357 AT  769 2343 AT 
727 2353 AT  770 2399 AT 
728 2309 TT  771 2383 AT 
729 2303 AT  772 2391 AT 
730 2329 AT  773 2335 TT 
731 2336 TT  774 2315 AT 
732 2311 TT  775 2320 AT 
733 2376 AT  776 2328 AT 
734 2375 TT  777 2395 AT 
735 2366 AT  778 2348 AT 
736 2350 AT  779 2352 AT 
737 2341 TT  780 2396 AT 
738 2373 AT  781 2367 AT 
739 2356 AT  782 2365 AT 
740 2358 AT  783 2363 AT 
741 2371 AT  784 2308 AT 
742 2331 TT  785 2346 AT 
743 2302 AT  786 2351 AT 
744 2312 TT  787 2347 AT 
745 2354 AT  788 2355 AT 
746 2323 AT  789 2327 AT 
747 2374 AT  790 2339 TT 
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Lab # 
Wing 
Band# Genotype 
 
Lab # 
Wing 
Band# Genotype 
791 2316 AT  796 2304 TT 
792 2340 TT  797 2342 AT 
793 2310 AT  798 2318 AT 
794 2398 AT  799 2393 AT 
795 1743 TT  800 2378 AT 
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APPENDIX B 
First-generation Trial Trimethylamine Data 
Yolk TMA (µg/g) Cage # Wing Band # 
Geno-
type 
Diet (% 
CM) Egg A Egg B Egg C CV 
871 2395 AT 18 64.99 35.96 55.70 27.71 
872 2010 AT 18 61.97 23.05 192.00 91.86 
873 1990 AT 18 46.57 19.43 52.35 43.93 
875 2389 AT 18 40.52 19.03 65.60 59.40 
877 2376 AT 18 . . . . 
1101 1801 AT 0 17.92 40.72 95.60 83.75 
1102 1840 AT 0 21.99 31.86 44.51 33.10 
1103 1810 AT 0 58.30 21.83 175.15 92.24 
1104 1853 AT 0 56.45 48.59 58.85 13.09 
1105 1889 TT 0 43.53 55.70 45.12 4.31 
1106 1880 AT 0 76.94 50.74 29.04 51.28 
1107 1939 AT 0 46.71 22.63 54.12 43.27 
1108 1833 TT 0 79.02 19.13 82.34 60.83 
1109 1862 AT 0 63.87 34.71 50.75 30.37 
1110 1931 AT 0 77.90 125.76 60.74 33.82 
1111 2243 TT 0 22.61 23.68 53.38 46.77 
1112 2218 TT 0 43.63 54.28 42.52 12.89 
1113 2244 TT 0 22.08 87.12 56.99 56.51 
1114 2331 TT 0 18.06 8.55 55.69 67.52 
1115 2307 TT 0 22.07 48.98 63.63 43.16 
1116 2385 TT 0 16.33 24.56 47.99 59.80 
1117 2270 TT 0 16.35 17.11 84.43 93.27 
1118 2368 TT 0 19.82 19.71 56.59 59.77 
1119 2346 AT 0 32.17 79.30 46.90 41.16 
1121 1831 AT 6 . . . . 
1122 1879 TT 6 64.21 51.32 61.39 9.12 
1123 1883 TT 6 79.57 87.64 95.69 12.36 
1124 1816 AT 6 16.35 25.11 59.84 60.86 
1125 1881 AT 6 19.39 24.94 58.45 63.79 
1126 1841 AT 6 . . . . 
1127 1878 AT 6 19.55 41.41 46.69 40.75 
1128 1954 AT 6 33.35 27.07 36.76 38.81 
1129 1830 AT 6 17.97 36.22 49.79 49.01 
1130 1868 AT 6 20.29 60.88 52.92 47.16 
1131 2176 TT 6 50.31 37.77 65.07 24.10 
 84 
Yolk TMA (µg/g) Cage # Wing Band # 
Geno-
type 
Diet  
(% CM) Egg A Egg B Egg C CV 
1132 2181 TT 6 38.39 19.32 54.06 27.69 
1133 2177 TT 6 27.70 25.35 56.88 49.78 
1134 1819 TT 6 95.55 36.39 87.21 43.04 
1135 2160 TT 6 103.10 . . . 
1136 2014 TT 6 69.24 50.31 96.19 29.05 
1137 2024 AT 6 49.55 44.28 65.99 19.82 
1138 1929 TT 6 106.39 57.64 88.91 30.28 
1139 1951 TT 6 162.31 123.52 155.19 15.83 
1140 2053 TT 6 60.63 51.06 88.12 27.06 
1141 2100 TT 12 49.19 88.80 119.79 37.67 
1142 2003 TT 12 63.53 77.93 105.08 26.98 
1143 2072 TT 12 135.93 77.05 124.15 29.77 
1144 1963 TT 12 139.38 117.96 130.73 12.71 
1145 1952 TT 12 116.39 137.40 251.79 40.63 
1146 2218 TT 12 25.18 24.85 54.36 47.80 
1147 1978 TT 12 81.00 118.70 153.56 32.79 
1148 2293 TT 12 29.54 49.91 87.50 71.50 
1149 1969 TT 12 107.03 128.97 119.81 2.80 
1150 1958 TT 12 47.24 75.38 117.82 41.04 
1151 1925 AT 12 20.73 18.72 60.32 72.17 
1152 1975 AT 12 15.69 13.74 54.15 78.80 
1153 1953 AT 12 19.31 18.31 56.15 68.49 
1154 1940 AT 12 19.94 30.90 74.41 61.66 
1155 1814 AT 12 21.56 51.54 65.02 43.51 
1156 1845 AT 12 21.44 52.47 26.44 53.65 
1157 1822 AT 12 19.34 63.67 63.73 52.05 
1158 1867 AT 12 25.94 29.18 77.05 66.92 
1159 1818 AT 12 16.34 24.49 26.23 23.06 
1160 1837 AT 12 20.93 79.97 56.17 55.82 
1161 2238 TT 18 178.90 220.42 210.84 19.72 
1162 2377 TT 18 159.25 121.58 116.02 23.53 
1163 2304 TT 18 89.29 124.35 111.32 18.31 
1164 2400 TT 18 43.55 63.90 71.15 28.02 
1165 2174 TT 18 85.33 142.18 110.56 21.53 
1166 2142 TT 18 183.41 264.20 279.85 18.14 
1167 2178 TT 18 157.11 123.77 129.20 16.60 
1168 2164 TT 18 127.82 84.02 121.17 24.67 
1169 2074 TT 18 98.84 113.38 157.00 29.55 
1170 2055 TT 18 121.59 132.49 142.77 53.85 
1171 1928 AT 18 21.08 65.52 58.90 50.74 
1172 1913 AT 18 16.92 15.56 55.12 80.45 
1173 1947 AT 18 23.50 22.80 27.20 4.44 
1174 1961 AT 18 27.84 28.73 25.51 0.00 
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Yolk TMA (µg/g) Cage # Wing Band # 
Geno-
type 
Diet  
(% CM) Egg A Egg B Egg C CV 
1175 1995 AT 18 25.22 66.23 64.75 46.30 
1176 1946 AT 18 21.28 39.84 68.58 54.09 
1177 2000 AT 18 130.44 25.86 59.29 69.99 
1178 1999 AT 18 17.39 24.05 60.88 62.84 
1179 1989 AT 18 23.34 26.21 30.25 4.02 
1180 1902 AT 18 101.83 132.41 106.56 17.55 
.
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APPENDIX C 
Second-generation Genotypes 
Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
101 1805 AA  135 1839 TT 
102 1806 AA  136 1831 AT 
103 1801 AT  137 1834 AT 
104 1803 TT  138 1840 AA 
105 1802 AT  139 1827 AT 
106 1804 AT  140 1833 TT 
107 1809 AA  141 1836 AA 
108 1807 AT  142 1843 AT 
109 1808 AT  143 1842  
110 1819 AT  144 1844 TT 
111 1813 TT  145 1845 AT 
112 1817 TT  146 1851 AT 
113 1810 TT  147 1850 TT 
114 1811 AA  148 1848 TT 
115 1814 AT  149 1847 AA 
116 1816 AT  150 1849 TT 
117 1815 AT  151 8058 AT 
118 1818 AA  152 1846 AT 
119 1812 AT  153 1853 TT 
120 1821 AT  154 1855 AT 
121 1826 TT  155 1860 AA 
122 1822 TT  156 1862 AT 
123 1824 AT  157 1856 AA 
124 1823 AT  158 1863 TT 
125 1820 TT  159 1857 AA 
126 1825 AT  160 1861 TT 
127 1835 AA  161 1859 AT 
128 1841 TT  162 1858 AT 
129 1832 AA  163 1864 AA 
130 1837 AT  164 1854 AT 
131 1838 AT  165 1865 AA 
132 1829 AA  166 1870 AA 
133 1828 AT  167 1869 AT 
134 1830 AT  168 1866 AT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
169 1867 AT  212 1913 - 
170 1868 AA  213 1907 AT 
171 1881 AT  214 1921 - 
172 1880 AT  215 1918 AT 
173 1871 AA  216 1926 AT 
174 1877 TT  217 1925 AA 
175 1879 AT  218 1924 AT 
176 1873 AT  219 1916 AT 
177 1884 AT  220 1919 AT 
178 1875 AT  221 1922 AT 
179 1882 TT  222 1920 AT 
180 1885 AT  223 1927 AT 
181 1872 TT  224 1923 AA 
182 1883 AA  225 1917 TT 
183 1878 AT  226 1915 AT 
184 1876 AT  227 1939 TT 
185 1874 AT  228 1940 TT 
186 1891 AA  229 1932 TT 
187 1894 AA  230 1938 TT 
188 1895 AT  231 1933 TT 
189 1889 AT  232 1936 TT 
190 1893 AT  233 1934 TT 
191 1897 AT  234 1930 TT 
192 1896 AT  235 1929 TT 
193 1888 AT  236 1942 TT 
194 1899 AT  237 1941 AT 
195 1890 AA  238 1928 TT 
196 1892 AA  239 1935 TT 
197 1887 AA  240 1937 TT 
198 1900 AT  241 1931 TT 
199 1898 AT  242 1950 TT 
200 1886 AA  243 1945 TT 
201 1912 AT  244 1954 AT 
202 1902 AT  245 1949 AT 
203 1911 AT  246 1951 TT 
204 1901 AT  247 1943 AT 
205 1906 TT  248 1946 AT 
206 1904 AT  249 1948 AT 
207 1909 TT  250 1944 TT 
208 1905 AT  251 1955 AT 
209 1910 AT  252 1947 TT 
210 5352 AT  253 1953 TT 
211 1908 TT  254 1952 TT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
255 1970 AT  298 1995 AT 
256 1961 TT  299 2000 TT 
257 1962 TT  300 2004 TT 
258 1965 TT  301 2003 AT 
259 1959 AT  302 2005 AT 
260 5350 AT  303 2002 TT 
261 1963 AT  304 2001 TT 
262 1956 TT  305 2006 AT 
263 1967 TT  306 2010 TT 
264 1966 TT  307 2008 AT 
265 1972 TT  308 2007 TT 
266 1958 AT  309 2009 AT 
267 1971 TT  310 2020 AT 
268 1964 TT  311 2012 AA 
269 1968 TT  312 2022 AA 
270 1957 AT  313 2017 TT 
271 1969 AT  314 2021 AA 
272 1979 TT  315 2011 AA 
273 1982 AT  316 2013 TT 
274 1977 TT  317 2025 TT 
275 1978 AT  318 2014 AT 
276 1984 TT  319 2024 TT 
277 1980 AT  320 2019 AT 
278 1975 TT  321 2018 AT 
279 1981 TT  322 2016 TT 
280 1973 AT  323 2015 AT 
281 1976 TT  324 2023 AT 
282 1985 TT  325 2028 AT 
283 1983 TT  326 2030 AT 
284 1974 AT  327 2026 TT 
285 1987 TT  328 2027 AT 
286 1990 AT  329 2034 AT 
287 1989 AT  330 2031 AT 
288 1993 TT  331 2035 AT 
289 1991 TT  332 2033 TT 
290 1998 AA  333 2029 AT 
291 5349 AT  334 2032 TT 
292 1999 TT  335 2044 TT 
293 1986 TT  336 2043 AT 
294 1996 TT  337 2047 AT 
295 1992 TT  338 2038 AT 
296 1997 TT  339 2039 AA 
297 1994 TT  340 2041 AT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
341 2037 AT  384 2098 AA 
342 2045 TT  385 2105 AT 
343 2036 AT  386 2107 AT 
344 2048 AT  387 2096 TT 
345 2040 TT  388 2106 AT 
346 2042 AT  389 2101 AA 
347 2046 AT  390 2100 AA 
348 2071 AA  391 2102 TT 
349 2063 AT  392 2108 AT 
350 2067 AT  393 2103 AT 
351 2073 AA  394 2099 AA 
352 2070 AT  395 2111 AA 
353 2064 AT  396 2118 TT 
354 2072 AT  397 2121 AT 
355 2062 AT  398 2122 AT 
356 2065 AT  399 2112 TT 
357 2068 TT  400 2117 AT 
358 2066 TT  401 2116 AT 
359 2076 AT  402 2123 AT 
360 2077 AA  403 2115 AA 
361 2079 TT  404 2114 TT 
362 2080 AA  405 2120 AT 
363 2078 AA  406 2125 TT 
364 2074 TT  407 2119 AA 
365 2075 AA  408 2124 AA 
366 2090 AA  409 2110 AT 
367 2087 AA  410 2113 AT 
368 2082 AT  411 2138 AT 
369 2085 TT  412 2142 AT 
370 2081 AT  413 2141 AA 
371 2094 AA  414 2140 TT 
372 2091 TT  415 2139 AA 
373 2089 TT  416 2157 AA 
374 2084 AA  417 2158 TT 
375 2086 AA  418 2160 AT 
376 2083 AA  419 2159 AT 
377 2088 AA  420 2156 AT 
378 2093 AT  421 2162 AT 
379 2092 AT  422 2155 AA 
380 2095 TT  423 2161 AT 
381 2104 AT  424 2164 AT 
382 2097 TT  425 2163 AT 
383 2109 AA  426 2147 AT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
427 2154 AT  470 2212 AT 
428 2148 TT  471 2216 TT 
429 2152 AT  472 2211 AT 
430 2151 AT  473 2239 AT 
431 2146 AA  474 2233 AT 
432 2149 AT  475 2232 AT 
433 2143 AA  476 2241 AA 
434 2153 TT  477 2237 AT 
435 2145 AA  478 2231 TT 
436 2150 AT  479 2235 AT 
437 2144 AT  480 2238 AT 
438 2183 AT  481 2240 TT 
439 2185 AT  482 2234 AT 
440 2186 TT  483 2236 AT 
441 2188 AT  484 2248 AT 
442 2184 AT  485 2242 AA 
443 2190 TT  486 2253 AT 
444 2189 AT  487 2250 AA 
445 2192 AT  488 2246 TT 
446 2187 TT  489 2252 AT 
447 2191 AT  490 2247 AT 
448 2200 AT  491 2245 AT 
449 2201 AA  492 2243 AT 
450 2202 AA  493 2249 TT 
451 2204 AA  494 2254 AA 
452 2196 AA  495 2251 AT 
453 2195 TT  496 2244 AA 
454 2203 TT  497 2273 AA 
455 2197 AT  498 2271 AA 
456 2198 AA  499 2266 TT 
457 2199 AT  500 2267 AA 
458 2194 TT  501 2268 AA 
459 2193 TT  502 2269 AT 
460 2218 AA  503 2276 AT 
461 2208 TT  504 2278 AA 
462 2207 AT  505 2275 TT 
463 2215 AT  506 2274 AT 
464 2205 AT  507 2279 AA 
465 2206 AA  508 2272 AT 
466 2217 AT  509 2270 AA 
467 2209 AT  510 2277 AT 
468 2213 AA  511 2265 AT 
469 2214 TT  512 2295 AT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
513 2291 AA  556 2356 TT 
514 2293 AT  557 2349 TT 
515 2297 AT  558 2357 AT 
516 2296 AT  559 2352 AA 
517 2298 AT  560 2355 AT 
518 2301 AT  561 2353 AA 
519 2300 AA  562 2351 TT 
520 2299 AA  563 2354 AT 
521 2294 AT  564 2379 TT 
522 2292 AT  565 2382 TT 
523 2307 AT  566 2378 AA 
524 2309 AA  567 2381 AT 
525 2306 AA  568 2380 AA 
526 2311 AT  569 2397 AA 
527 2304 AT  570 2388 AT 
528 2318 AT  571 2396 AT 
529 2315 AA  572 2387 AA 
530 2313 AT  573 2383 AA 
531 2308 AT  574 2394 AA 
532 2302 TT  575 2385 AA 
533 2316 AA  576 2386 TT 
534 2305 TT  577 2389 TT 
535 2312 AT  578 2391 AA 
536 2317 AT  579 2392 AA 
537 2310 TT  580 2395 TT 
538 2303 TT  581 2390 AT 
539 2314 TT  582 2393 AA 
540 2343 TT  583 2398 AT 
541 2338 TT  584 2384 AT 
542 2347 AT  585 2400 AA 
543 2344 AT  586 2404 TT 
544 2342 AT  587 2406 AT 
545 2334 AT  588 2409 AT 
546 2348 AT  589 2414 AT 
547 2337 AT  590 2412 TT 
548 2341 TT  591 2411 TT 
549 2335 AT  592 2403 AT 
550 2340 AA  593 2399 AA 
551 2339 AA  594 2413 AT 
552 2345 AT  595 2408 TT 
553 2336 AT  596 2402 AT 
554 2346 AT  597 2405 AA 
555 2350 AT  598 2401 TT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
599 2407 TT  642 8059 AT 
600 2410 AT  643 2482 AT 
601 2442 AA  644 2477 AA 
602 2449 AA  645 2481 TT 
603 2441 AT  646 2475 AT 
604 2439 AA  647 2480 AA 
605 2446 TT  648 2476 AT 
606 2440 TT  649 2484 AT 
607 2448 AA  650 2525 TT 
608 2447 TT  651 2524 AT 
609 2445 AT  652 2532 TT 
610 2443 TT  653 2527 AA 
611 2444 TT  654 2531 TT 
612 2474 TT  655 2530 AT 
613 2467 AT  656 2529 TT 
614 2465 TT  657 2528 TT 
615 2464 AA  658 2526 TT 
616 2463 AA  659 2546 AT 
617 2470 AT  660 2549 AT 
618 2473 AA  661 2548 AT 
619 2468 AA  662 2552 AT 
620 2469 AT  663 2550 AT 
621 2471 TT  664 2551 AT 
622 2472 TT  665 2547 AA 
623 2466 AT  666 2557 AT 
624 2462 TT  667 2555 AT 
625 2500 TT  668 2559 AT 
626 2496 AA  669 2554 AT 
627 2499 AA  670 2558 TT 
628 2497 AA  671 2556 AA 
629 2491 TT  672 2553 AT 
630 2493 AT  673 2561 AT 
631 2494 TT  674 2564 AT 
632 2489 AT  675 2565 AT 
633 2495 AT  676 2562 AT 
634 2492 AT  677 2560 AT 
635 2490 TT  678 2563 AT 
636 2501 AT  679 2566 AA 
637 2506 TT  680 2576 AT 
638 2507 TT  681 2579 AA 
639 2502 AT  682 2574 AA 
640 2505 TT  683 2578 AT 
641 2503 AT  684 2577 AT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
685 2575 AT  1223 2583 AT 
686 2580 TT  1224 2572 AT 
687 2594 AT  1225 2569 TT 
688 2593 AA  1226 2568 AT 
689 2588 AT  1227 2571 AT 
690 2590 AT  1228 2573 AT 
691 2589 AT  1229 2567 AA 
692 2591 AT  1230 2570 TT 
693 2592 AT  1231 2543 AA 
694 2597 AT  1232 2540 AA 
695 2596 AT  1233 2545 AT 
696 2595 AT  1234 2544 TT 
697 2598 TT  1235 2542 AT 
698 2601 TT  1236 2539 AT 
699 2600 TT  1237 2541 AA 
700 2599 AA  1238 2516 AA 
701 2615 AA  1239 2515 AT 
702 2612 AA  1240 2517 AT 
703 2614 TT  1241 2519 AT 
704 2610 TT  1242 2514 AT 
705 2609 AT  1243 2518 TT 
706 2613 AT  1244 2513 TT 
707 2611 AT  1245 2522 AT 
1203 2616 AA  1246 2523 TT 
1204 2618 AT  1247 2520 TT 
1205 2617 AT  1248 2521 TT 
1206 2619 AT  1249 2509 TT 
1207 2620 TT  1250 2511 TT 
1208 2621 TT  1251 2512 TT 
1209 2622 AA  1252 2508 TT 
1210 2602 AT  1253 2510 TT 
1211 2604 AA  1254 2460 AT 
1212 2603 TT  1255 2451 AT 
1213 2606 TT  1256 2459 TT 
1214 2607 AT  1257 2455 AT 
1215 2605 TT  1258 2456 AA 
1216 2608 AT  1259 2454 AA 
1217 2587 AT  1260 2453 AT 
1218 2585 AT  1261 2458 AT 
1219 2586 AT  1262 2457 TT 
1220 2581 AA  1263 2452 TT 
1221 2582 AT  1264 2450 AT 
1222 2584 TT  1265 2461 AA 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
1266 2434 AT  1309 2362 TT 
1267 2437 AT  1310 2320 TT 
1268 2422 AT  1311 2326 TT 
1269 2431 AT  1312 2319 AT 
1270 2424 TT  1313 2329 TT 
1271 2430 AT  1314 2324 TT 
1272 2435 TT  1315 2331 AT 
1273 2427 AA  1316 2328 AT 
1274 2436 AA  1317 2332 AT 
1275 2432 TT  1318 2325 AT 
1276 2425 AT  1319 2322 AT 
1277 2438 AT  1320 2327 TT 
1278 2426 AT  1321 2321 AT 
1279 2428 AT  1322 2333 TT 
1280 2429 AA  1323 2330 AT 
1281 2433 AT  1324 2323 AT 
1282 2423 AA  1325 2288 AT 
1283 2415 AT  1326 2286 AA 
1284 2419 AT  1327 2289 TT 
1285 2416 TT  1328 2290 AT 
1286 2418 TT  1329 2280 AA 
1287 2420 AA  1330 2283 TT 
1288 2421 AT  1331 2285 AT 
1289 2417 TT  1332 2287 TT 
1290 2371 AA  1333 2282 AT 
1291 2377 AA  1334 2284 AT 
1292 2368 AA  1335 2281 AT 
1293 2375 AT  1336 2258 AT 
1294 2373 AT  1337 2260 AT 
1295 2370 AT  1338 2257 TT 
1296 2374 AT  1339 2262 TT 
1297 2372 AT  1340 2256 AA 
1298 2376 AT  1341 2264 TT 
1299 2369 TT  1342 2261 TT 
1300 2363 TT  1343 2263 TT 
1301 2358 TT  1344 2259 AT 
1302 2364 AT  1345 2255 AT 
1303 2359 AT  1346 2221 AT 
1304 2365 AT  1347 2220 AT 
1305 2361 TT  1348 2219 AT 
1306 2360 TT  1349 2224 AT 
1307 2366 AT  1350 2227 TT 
1308 2367 TT  1351 2228 TT 
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Lab # Wing Band # Genotype  Lab # 
Wing 
Band # Genotype 
1352 2223 AT  1377 2137 AT 
1353 2230 AA  1378 2131 AT 
1354 2225 AA  1379 2135 AA 
1355 2222 TT  1380 2133 AT 
1356 2229 AT  1381 2134 AA 
1357 2226 TT  1382 2128 AT 
1358 2182 AA  1383 2136 AT 
1359 2166 TT  1384 2132 TT 
1360 2174 TT  1385 2129 AT 
1361 2177 AT  1386 2126 AT 
1362 2176 TT  1387 2127 AT 
1363 2181 AT  1388 2051 AT 
1364 2170 TT  1389 2052 AT 
1365 2167 TT  1390 2055 AA 
1366 2180 AT  1391 - AT 
1367 2165 AT  1392 - TT 
1368 2171 AT  1393 - AA 
1369 2175 TT  1394 - AT 
1370 2178 AT  1395 - AT 
1371 2179 AA  1396 - TT 
1372 2168 TT  1397 - AT 
1373 2169 AA  1398 - TT 
1374 2173 AT  1399 - AT 
1375 2172 AT  1400 - AT 
1376 2130 AA     
 
.
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APPENDIX D 
Second-generation Trial Trimethylamine Data 
Yolk TMA (µg/g) Wing 
Band # 
Cage 
# 
Geno-
type Diet Egg1 Egg2 Egg3 
CV 
Serum 
TMA 
(µg/ml) 
2286 241 AA 0 0.98 0.78 1.68 41.21 0.189 
2271 242 AA 0 1.70 0.84 3.17 61.90 0.120 
1864 371 AA 0 2.59 0.97 1.26 86.38 0.103 
2115 372 AA 0 0.88 1.87 3.75 47.44 . 
1892 373 AA 0 4.94 7.95 2.99 60.59 0.189 
2429 380 AA 0 1.67 0.91 1.19 65.90 0.155 
2492 368 AT 0 1.42 1.62 2.25 84.39 0.137 
2585 369 AT 0 1.48 1.19 3.02 34.28 0.189 
2103 370 AT 0 5.45 4.18 6.08 63.16 . 
2180 377 AT 0 2.84 0.86 4.84 28.84 0.103 
2104 378 AT 0 1.55 0.73 0.91 51.28 0.240 
2212 379 AT 0 5.96 1.22 4.04 56.44 0.189 
1953 365 TT 0 1.47 3.87 . 22.86 . 
1994 366 TT 0 5.80 7.35 . 6.39 0.155 
1997 367 TT 0 1.70 1.85 3.98 30.53 0.137 
2526 374 TT 0 1.29 1.02 3.45 43.85 0.155 
1862 375 TT 0 1.22 1.04 1.41 57.24 0.000 
2158 376 TT 0 0.66 4.92 5.82 65.99 0.223 
2581 258 AA 6 1.31 1.27 3.16 33.82 0.189 
2179 259 AA 6 1.24 1.26 1.82 . 0.172 
2497 260 AA 6 1.59 1.40 1.52 33.82 . 
1923 261 AA 6 5.47 6.87 3.63 35.34 0.155 
2385 262 AA 6 1.37 1.83 3.16 24.08 0.206 
2316 263 AA 6 1.37 4.39 5.55 17.50 . 
2197 249 AT 6 2.38 1.04 6.54 10.99 0.155 
2014 250 AT 6 1.14 1.83 3.01 44.97 0.189 
2105 251 AT 6 1.06 1.21 2.96 35.77 0.137 
2113 264 AT 6 1.26 2.10 4.64 22.44 0.206 
2265 265 AT 6 1.40 2.08 2.82 68.04 0.137 
1901 266 AT 6 . . . 16.77 . 
2327 252 TT 6 5.73 1.01 4.25 57.17 0.120 
2569 253 TT 6 5.35 1.12 1.69 . 0.137 
1951 254 TT 6 2.00 3.28 . 12.63 0.189 
1977 255 TT 6 5.72 1.40 3.19 9.32 0.137 
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Yolk TMA (µg/g) Wing 
Band # 
Cage 
# 
Geno-
type Diet Egg1 Egg2 Egg3 
CV 
Serum 
TMA 
(µg/ml) 
1867 256 TT 6 . 1.21 1.83 102.46 0.206 
2025 257 TT 6 3.82 1.24 4.03 49.35 0.155 
2088 350 AA 12 1.06 1.32 1.60 65.34 0.155 
2464 351 AA 12 0.96 1.16 1.07 20.36 0.206 
2157 352 AA 12 1.34 2.07 1.60 9.42 0.155 
2204 356 AA 12 5.40 4.68 1.09 22.16 0.120 
2230 357 AA 12 4.56 1.06 3.40 40.05 0.206 
2071 358 AA 12 1.09 0.97 1.32 25.14 0.015 
2178 341 AT 12 3.52 1.40 1.02 83.82 0.189 
2322 342 AT 12 1.21 1.57 1.69 62.01 . 
2396 343 AT 12 1.37 4.89 5.57 59.30 0.086 
2530 347 AT 12 1.09 1.42 6.69 15.79 0.137 
2562 348 AT 12 1.16 2.25 3.40 63.56 0.137 
2590 349 AT 12 1.22 1.70 4.06 16.67 0.120 
2443 344 TT 12 7.58 . . 50.81 . 
1824 345 TT 12 2.96 3.68 3.75 24.57 0.292 
1820 346 TT 12 4.86 4.48 4.03 51.86 0.172 
2263 353 TT 12 13.05 5.95 14.03 18.48 0.155 
2013 354 TT 12 3.07 1.85 2.38 53.77 0.275 
2379 355 TT 12 6.61 2.36 1.21 67.28 0.189 
2099 1307 AA 18 0.94 1.97 1.06 47.21 0.155 
2547 1308 AA 18 3.16 2.91 . 69.37 . 
1857 1309 AA 18 0.86 1.83 1.22 15.12 0.155 
1886 1316 AA 18 1.12 0.88 1.22 72.53 0.086 
2405 1317 AA 18 1.39 0.96 1.11 69.91 0.189 
2134 1318 AA 18 1.44 1.17 1.37 40.53 0.103 
1873 1301 AT 18 4.94 1.21 6.63 63.75 0.120 
2276 1302 AT 18 2.64 1.69 1.17 30.59 0.155 
2475 1303 AT 18 2.83 0.91 1.48 48.07 0.189 
1912 1310 AT 18 1.14 0.45 1.67 51.53 0.103 
2466 1311 AT 18 2.23 0.97 1.42 56.21 0.120 
2546 1312 AT 18 0.89 1.85 3.11 54.11 0.052 
2168 1304 TT 18 5.44 3.29 18.16 54.43 0.275 
2407 1305 TT 18 5.11 1.34 8.01 125.65 0.206 
1940 1306 TT 18 7.09 4.73 8.61 115.85 0.292 
1962 1313 TT 18 7.86 3.39 4.69 68.23 0.206 
2208 1314 TT 18 3.52 3.44 8.56 122.13 0.549 
2401 1315 TT 18 2.30 1.87 2.08 115.93 0.240 
2244 279 AA 24 1.17 2.41 2.40 65.10 0.223 
2182 280 AA 24 2.15 2.15 3.11 40.66 0.103 
2499 1285 AA 24 1.34 1.72 3.25 56.67 0.120 
2256 1292 AA 24 1.49 1.27 4.06 89.66 0.206 
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Yolk TMA (µg/g) Wing 
Band # 
Cage 
# 
Geno-
type Diet Egg1 Egg2 Egg3 
CV 
Serum 
TMA 
(µg/ml) 
2201 1293 AA 24 1.29 1.16 10.01 69.39 0.086 
2339 1294 AA 24 1.17 11.81 . 28.71 0.137 
2332 273 AT 24 3.29 1.67 3.26 42.56 0.172 
2205 274 AT 24 3.72 4.03 6.84 5.82 . 
2319 275 AT 24 1.98 2.66 1.67 37.62 0.103 
2554 1289 AT 24 5.27 1.44 4.13 56.30 0.189 
2336 1290 AT 24 0.45 7.62 . 41.46 0.137 
2455 1291 AT 24 1.31 1.24 9.00 57.10 0.292 
1939 276 TT 24 9.62 7.58 10.81 43.27 0.206 
1854 277 TT 24 5.49 4.76 4.44 56.70 0.155 
1968 278 TT 24 8.87 4.59 . 10.32 0.120 
2198 1286 TT 24 8.54 5.07 14.66 16.28 . 
2606 1287 TT 24 6.16 5.62 14.36 18.92 0.240 
2363 1288 TT 24 8.03 3.59 3.22 10.56 0.155 
1858 243 TT 0.11 1.44 3.47 . 58.47 2.454 
1991 244 TT 0.11 1.44 1.07 . 20.85 1.257 
2500 245 TT 0.11 0.89 1.55 . 38.25 1.223 
2435 246 TT 0.11 1.02 1.70 1.83 28.68 1.520 
2446 247 TT 0.11 1.70 0.99 1.21 27.96 1.300 
2203 248 TT 0.11 1.65 1.02 1.32 23.69 1.333 
2408 267 TT 0.055 1.19 1.60 2.97 48.55 1.921 
1947 268 TT 0.055 1.21 5.68 3.45 64.85 3.448 
1933 269 TT 0.055 2.15 6.13 3.47 51.76 3.916 
2621 270 TT 0.055 0.99 1.52 1.70 26.30 1.404 
1850 271 TT 0.055 1.59 6.69 9.81 68.82 5.260 
2521 272 TT 0.055 1.93 3.39 1.95 34.55 2.423 
2002 359 TT 0.165 6.05 4.56 1.14 64.27 3.916 
2601 360 TT 0.165 1.06 1.29 3.98 76.95 2.109 
2531 361 TT 0.165 2.28 3.65 1.26 50.04 2.396 
2262 362 TT 0.165 3.92 5.82 . 27.59 4.866 
2246 363 TT 0.165 1.49 1.48 0.74 34.78 1.237 
2310 364 TT 0.165 1.19 0.96 1.31 15.42 1.151 
1961 1295 TT 0.22 2.40 2.08 10.18 93.87 4.885 
2508 1296 TT 0.22 1.44 1.17 1.17 12.37 1.261 
2079 1297 TT 0.22 5.73 1.31 13.93 91.61 6.989 
2386 1298 TT 0.22 5.35 1.17 3.04 65.71 3.189 
2351 1299 TT 0.22 2.31 1.39 3.77 48.20 2.489 
1818 1300 TT 0.22 7.15 1.12 3.02 81.92 3.767 
.
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APPENDIX E 
Second-generation Trial Production Data 
Cage 
# 
Geno-
type 
Diet Hen 
Days 
(egg) 
Total 
Eggs 
HD 
Producti
on 
Initial 
Wt 
(kg) 
End 
Wt 
(kg) 
Hen 
Days 
(wt) 
ADG 
(g/d) 
241 AA 0 19 19 1.00 2.24 2.21 26.00 -2.31 
242 AA 0 19 15 0.79 2.37 2.28 26.00 -0.38 
243 TT 0.11 19 15 0.79 2.51 2.45 26.00 -1.15 
244 TT 0.11 19 17 0.89 1.87 1.86 26.00 1.54 
245 TT 0.11 19 10 0.53 1.43 1.46 26.00 -1.54 
246 TT 0.11 19 17 0.89 1.97 1.94 26.00 -2.31 
247 TT 0.11 19 16 0.84 2.31 2.37 26.00 2.31 
248 TT 0.11 19 15 0.79 2.73 2.67 26.00 -0.77 
249 AT 6 19 17 0.89 2.10 2.16 26.00 2.31 
250 AT 6 19 14 0.74 2.43 2.33 26.00 -3.85 
251 AT 6 19 12 0.63 2.28 2.31 26.00 1.15 
252 TT 6 19 19 1.00 1.86 1.85 26.00 -0.38 
253 TT 6 19 15 0.79 1.99 1.97 26.00 -0.77 
254 TT 6 19 16 0.84 1.52 1.38 26.00 -5.38 
255 TT 6 19 14 0.74 1.94 1.87 26.00 -2.69 
256 TT 6 19 16 0.84 2.31 2.22 26.00 -3.46 
257 TT 6 19 18 0.95 2.43 2.43 26.00 0.00 
258 AA 6 19 15 0.79 2.33 2.26 26.00 -2.69 
259 AA 6 19 17 0.89 2.06 1.93 26.00 -5.00 
260 AA 6 19 17 0.89 1.83 1.79 26.00 -1.54 
261 AA 6 19 18 0.95 2.40 2.24 26.00 -6.15 
262 AA 6 19 16 0.84 1.98 1.98 26.00 0.00 
263 AA 6 19 16 0.84 2.53 2.57 26.00 1.54 
264 AT 6 19 19 1.00 2.02 2.01 26.00 -0.38 
265 AT 6 19 18 0.95 2.64 2.72 26.00 3.08 
266 AT 6 15 13 0.87 2.42 2.30 22.00 -5.45 
267 TT 0.055 19 18 0.95 2.00 1.95 26.00 -1.15 
268 TT 0.055 19 16 0.84 2.37 2.32 26.00 -3.46 
269 TT 0.055 19 17 0.89 1.91 2.03 26.00 -7.69 
270 TT 0.055 19 17 0.89 1.97 1.96 26.00 -2.31 
271 TT 0.055 19 18 0.95 2.08 2.13 26.00 1.92 
272 TT 0.055 19 19 1.00 1.93 1.95 26.00 -1.15 
273 AT 24 19 18 0.95 2.31 2.27 26.00 -1.54 
274 AT 24 19 17 0.89 2.64 2.52 26.00 -4.62 
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275 AT 24 19 15 0.79 2.37 2.56 26.00 7.31 
276 TT 24 19 16 0.84 1.88 1.95 26.00 2.69 
277 TT 24 19 14 0.74 1.83 1.88 26.00 1.92 
278 TT 24 19 15 0.79 2.12 2.07 26.00 -1.92 
279 AA 24 19 16 0.84 2.60 2.52 26.00 -3.08 
280 AA 24 19 11 0.58 1.98 2.06 26.00 3.08 
341 AT 12 19 16 0.84 2.08 2.08 26.00 0.00 
342 AT 12 19 18 0.95 2.43 2.37 26.00 -2.31 
343 AT 12 19 15 0.79 2.37 2.28 26.00 -3.46 
344 TT 12 6 5 0.83 2.35 2.34 6.00 -1.67 
345 TT 12 19 15 0.79 1.80 1.78 26.00 -0.77 
346 TT 12 19 16 0.84 2.11 2.06 26.00 -1.92 
347 AT 12 19 18 0.95 2.22 2.24 26.00 0.77 
348 AT 12 19 16 0.84 2.65 2.46 26.00 -7.31 
349 AT 12 19 16 0.84 2.02 2.05 26.00 1.15 
350 AA 12 19 18 0.95 2.24 2.15 26.00 -3.46 
351 AA 12 19 18 0.95 2.53 2.35 26.00 -6.92 
352 AA 12 19 17 0.89 1.51 1.56 26.00 1.92 
353 TT 12 19 11 0.58 1.82 1.91 26.00 3.46 
354 TT 12 19 18 0.95 2.14 2.24 26.00 3.85 
355 TT 12 19 19 1.00 2.34 2.37 26.00 1.15 
356 AA 12 19 15 0.79 1.84 1.85 26.00 0.38 
357 AA 12 19 18 0.95 2.66 2.68 26.00 0.77 
358 AA 12 19 14 0.74 2.42 2.44 26.00 0.77 
359 TT 0.165 19 19 1.00 2.17 2.25 26.00 -1.92 
360 TT 0.165 19 16 0.84 1.75 1.70 26.00 -3.85 
361 TT 0.165 19 18 0.95 2.32 2.27 26.00 1.92 
362 TT 0.165 19 15 0.79 2.31 2.26 26.00 5.77 
363 TT 0.165 19 15 0.79 2.54 2.48 26.00 -11.15 
364 TT 0.165 19 19 1.00 2.06 2.06 26.00 -3.08 
365 TT 0 19 12 0.63 2.37 2.32 26.00 -4.62 
366 TT 0 19 12 0.63 2.28 2.18 26.00 -7.31 
367 TT 0 19 7 0.37 2.29 2.34 26.00 3.85 
368 AT 0 19 18 0.95 2.76 2.73 26.00 3.08 
369 AT 0 19 16 0.84 2.21 2.25 26.00 -1.92 
370 AT 0 19 16 0.84 2.56 2.52 26.00 -1.92 
371 AA 0 19 18 0.95 2.18 1.98 26.00 1.15 
372 AA 0 19 14 0.74 1.69 1.63 26.00 -1.15 
373 AA 0 19 15 0.79 2.10 2.15 26.00 2.31 
374 TT 0 19 18 0.95 2.61 2.76 26.00 -2.31 
375 TT 0 19 10 0.53 1.97 1.68 26.00 3.85 
376 TT 0 19 16 0.84 2.80 2.72 26.00 6.54 
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377 AT 0 19 15 0.79 2.26 2.20 26.00 -1.92 
378 AT 0 19 15 0.79 2.15 2.21 26.00 -2.31 
379 AT 0 19 17 0.89 1.77 1.75 26.00 0.00 
380 AA 0 19 11 0.58 2.99 2.96 26.00 -2.31 
1285 AA 24 19 14 0.74 1.65 1.68 26.00 1.15 
1286 TT 24 19 15 0.79 2.50 2.39 26.00 -4.23 
1287 TT 24 19 16 0.84 1.87 1.98 26.00 4.23 
1288 TT 24 19 17 0.89 2.46 2.46 26.00 0.00 
1289 AT 24 19 14 0.74 1.68 1.72 26.00 1.54 
1290 AT 24 19 6 0.32 2.07 2.12 26.00 1.92 
1291 AT 24 19 16 0.84 1.76 1.82 26.00 2.31 
1292 AA 24 19 16 0.84 1.84 1.96 26.00 4.62 
1293 AA 24 19 19 1.00 2.05 2.13 26.00 3.08 
1294 AA 24 19 10 0.53 2.13 2.08 26.00 -1.92 
1295 TT 0.22 19 17 0.89 2.06 1.94 26.00 -1.92 
1296 TT 0.22 19 17 0.89 2.15 1.96 26.00 -1.92 
1297 TT 0.22 19 14 0.74 2.68 2.78 26.00 4.62 
1298 TT 0.22 19 15 0.79 2.20 2.14 26.00 -0.38 
1299 TT 0.22 19 15 0.79 2.42 2.52 26.00 1.92 
1300 TT 0.22 19 17 0.89 2.19 2.36 26.00 0.77 
1301 AT 18 19 14 0.74 2.24 2.36 26.00 4.62 
1302 AT 18 19 18 0.95 1.79 1.85 26.00 2.31 
1303 AT 18 19 18 0.95 2.56 2.38 26.00 -6.92 
1304 TT 18 19 14 0.74 1.64 1.74 26.00 3.85 
1305 TT 18 19 16 0.84 2.13 2.16 26.00 1.15 
1306 TT 18 19 16 0.84 1.85 1.89 26.00 1.54 
1307 AA 18 19 15 0.79 1.93 1.89 26.00 -1.54 
1308 AA 18 8 6 0.75 2.12 2.04 8.00 -10.00 
1309 AA 18 19 17 0.89 2.50 2.50 26.00 0.00 
1310 AT 18 19 17 0.89 2.53 2.47 26.00 -2.31 
1311 AT 18 19 19 1.00 2.27 2.19 26.00 -3.08 
1312 AT 18 19 12 0.63 2.07 2.13 26.00 2.31 
1313 TT 18 19 15 0.79 1.90 1.97 26.00 2.69 
1314 TT 18 19 17 0.89 2.16 2.18 26.00 0.77 
1315 TT 18 19 19 1.00 2.32 2.29 26.00 -1.15 
1316 AA 18 19 16 0.84 1.94 2.00 26.00 2.31 
1317 AA 18 19 14 0.74 2.09 2.03 26.00 -2.31 
1318 AA 18 19 18 0.95 2.74 2.55 26.00 -7.31 
 
.
 102 
APPENDIX F 
Other Strain Genotypes 
Lohmann Brown Lohmann WLH ISA Brown 
Lab # Genotype Lab # Genotype Lab # Genotype 
9013 AA 11 AA 8801 AA 
9019 AT 12 AA 8802 AA 
9027 AT 16 AA 8805 TT 
9028 AT 18 AA 8806 AT 
9029 AA 30 AA 8811 AA 
9030 AT 31 AA 8812 TT 
9032 AA 33 AA 8813 AT 
9033 AA 40 AA 8814 AA 
9034 AA 46 AA 8815 AT 
9036 AT 56 AA 8816 AA 
9041 AA 62 AA 8817 AT 
9043 AA 66 AA 8818 AT 
9045 AT 68 AA 8819 TT 
9046 AA 71 AA 8823 AT 
9048 AT 76 AA 8826 AA 
9052 AT 78 AA 8827 AA 
9053 AA 89 AA 8828 AA 
9054 AT 93 AA 8830 TT 
9055 AT 103 AA 8832 TT 
9057 AA 135 AA 8833 TT 
9058 AA 149 AA 8834 AA 
9059 AT 176 AA 8837 AA 
9060 AA 180 AA 8839 AA 
9062 AT 202 AA 8840 AT 
9063 AT 206 AA 8842 AA 
9068 AT 220 AA 8843 TT 
9069 AT 223 AA 8844 AT 
9071 AA 228 AA 8849 AA 
9073 AT 240 AA 8852 AT 
9075 AT 261 AA 8857 AT 
9076 AT 262 AA 8858 AA 
9078 AT 268 AA 8859 AA 
9081 AA 278 AA 8860 AT 
9087 AT 287 AA 8861 AT 
9088 AA 289 AA 8862 AT 
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Lohmann Brown Lohmann WLH ISA Brown 
Lab # Genotype Lab # AA Lab # Genotype 
9089 AA 308 AA 8866 TT 
9092 AT 309 AA 8867 AT 
9093 AT 318 AA 8869 AT 
9096 AA 319 AA 8875 AA 
9098 AT 325 AA 8887 TT 
9099 AA 331 AA 8888 AA 
9108 AA 331 AA 8889 AA 
9114 AT 333 AA 8890 AT 
9115 AA 360 AA 8892 AT 
9119 AT 369 AA 8893 AT 
9120 AT 389 AA 8894 AA 
9122 AT 409 AA 8897 AT 
9123 AA 428 AA 8898 AT 
9124 AA 452 AA 8903 AA 
9125 AA 457 AA 8905 AT 
9126 AT 458 AA 8909 AT 
9129 AA 466 AA 8910 TT 
9133 AT 531 AA 8911 AA 
9134 AT 534 AA 8912 AA 
9138 AA 539 AA 8916 AT 
9139 AT 542 AA 8917 AA 
9140 AA 547 AA 8918 AA 
9141 AT 559 AA 8920 AA 
9142 AA 571 AA 8923 AT 
9145 AT 581 AA 8924 AT 
9148 AA 593 AA 8925 AT 
9149 AT 611 AA 8927 AT 
9151 AA 619 AA 8930 AT 
9154 AA 622 AA 8932 AA 
9155 AT 626 AA 8933 AT 
9157 AA 634 AA 8934 AA 
9158 AT 639 AA 8935 AA 
9160 AA 662 AA 8936 AT 
9162 AA 663 AA 8937 AA 
9164 AT 680 AA 8938 AT 
9165 AT 701 AA 8946 AA 
9166 AA 714 AA 8952 AA 
9167 AT 721 AA 8957 AA 
9169 AT 725 AA 8965 AA 
9170 AA 743 AA 8969 TT 
9171 AT 750 AA 8970 AT 
9174 AA 752 AA 8973 AT 
9175 AT 760 AA 8978 AT 
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Lohmann Brown Lohmann WLH ISA Brown 
Lab # Genotype Lab # Genotype Lab # Genotype 
9177 AT 777 AA 8980 AA 
9180 AA 794 AA 8981 AA 
9181 AT 807 AA 8983 AA 
9183 TT 826 AA 8985 AA 
9185 AA 829 AA 8986 AA 
9186 AA 840 AA 8989 TT 
9188 AT 845 AA 8996 AT 
9189 AT 847 AA 8997 AA 
9191 AT 859 AA 9000 AT 
9192 AT 861 AA 9001 AT 
9195 AT 878 AA 9007 TT 
9197 AA   9012 AT 
9198 AA   9013 AA 
9200 AA   9019 AT 
9203 AT   9025 AA 
9205 AA     
9209 AA     
9211 AT     
9213 AT     
9215 AT     
9220 AA     
9223 AT     
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WPC Abstract 
XXIII World’s Poultry Congress, June 30-July 4, 2008, Brisbane, Australia. 
 
Dietary and genetic interactions in fishy egg tainting in brown-shelled layers 
 
A.K. Ward*, H.L. Classen and F.C. Buchanan  
 
Department of Animal and Poultry Science, University of Saskatchewan, SK, Canada 
alison.ward@usask.ca 
 
Fishy egg tainting is a problem associated with feeding canola meal (CM) to brown-
shelled laying hens.  It is caused by a single nucleotide polymorphism (A to T 
transversion) in flavin containing monooxygenase 3 (FMO3), which leads 
trimethylamine accumulation (TMA) in the yolk.  The purpose of this study was to 
characterize the effects of FMO3 genotype and level of dietary CM on egg TMA, as 
well as to observe daily variation in egg TMA for individual hens. Commercial laying 
hens were genotyped at FMO3, with 43 AT (heterozygous) and 41 TT (homozygous for 
tainting) hens used in this trial.  Approximately 10 hens of each genotype were allocated 
to one of four dietary treatments: 0, 6, 12, or 18% CM.  Diets were fed for 3 weeks prior 
to collecting 3 eggs per hen for TMA analysis. Level of CM did not affect yolk TMA 
content in AT hens with mean values of 3.53, 2.34, 2.29 and 2.90 µg/g for 0, 6, 12, 18% 
CM inclusion, respectively. In contrast, yolk TMA increased linearly (2.58, 4.50, 6.52, 
8.03 µg/g) with diet CM level for TT hens. Significant variation (P<0.05) was found in 
yolk TMA levels for eggs derived from the same hen. These data confirm the recessive 
nature of the T mutation and indicate that limits for dietary CM are not required for AT 
hens. 
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WPC Short Paper 
XXIII World’s Poultry Congress, June 30-July4, 2008, Brisbane, Australia. 
 
DIETARY AND GENETIC INTERACTIONS IN FISHY EGG TAINTING IN 
BROWN-SHELLED LAYERS 
 
A.K. WARD, H.L. CLASSEN AND F.C. BUCHANAN 
 
Fishy egg tainting is a problem associated with feeding canola meal (CM) to brown-
shelled laying hens.  It is caused by an A to T transversion at nucleotide 1043 in flavin 
containing monooxygenase 3 (FMO3 g1043A>T), which leads to trimethylamine 
accumulation (TMA) in the yolk (Honkatukia et al., 2005).  The purpose of this study 
was to characterize the effects of FMO3 genotype and level of dietary CM on egg TMA, 
as well as to observe daily variation in egg TMA for individual hens. Commercial laying 
hens were genotyped at FMO3 g1043A>T, with 43 AT (heterozygous) and 41 TT 
(homozygous for tainting) hens used in this trial.  Approximately 10 hens of each 
genotype were allocated to one of four dietary treatments: 0, 60, 120, or 180 g/kg CM.  
Diets were fed for 3 weeks prior to collecting 3 eggs per hen for TMA analysis.  Data 
were analyzed as a two by four factorial design using the mixed procedure of SAS 
version 9.1, with P<0.05 as significant.  Means were separated using Tukey’s Honestly 
Significant Difference Test.  The relationship between level of diet CM and egg TMA 
content were also examined within genotypes using the correlation procedure of SAS.   
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Significant variation (P=0.0033) was found between yolk TMA levels for eggs derived 
from the same hen. The effects of diet, genotype, and their interaction were highly 
significant (P<0.0001).  There was a significant linear correlation between yolk TMA 
and dietary CM for the TT hens (P<0.0001, R2=0.64) but not for the AT hens.  It can 
therefore be concluded that CM inclusion does not cause egg tainting in hens of the AT 
genotype for FMO3 g1043A>T.  These data confirm the recessive nature of the T 
mutation and indicate that limits for dietary CM are not required for AT hens. 
 
Honkatukia, M., Reese, K., Preisinger, R., Tuiskula-Haavisto, M., Weigend, S., Roito, 
J., Mäki-Tanila, A. and Vilkki, J. (2005).  Genomics, 86:225-232. 
 
Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, 
Saskatchewan, Canada S7N 5A8. 
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ISAG Abstract 
International Society for Animal Genetics XXXI, July 20-24, 2008, Amsterdam, The 
Netherlands. 
 
Fishy-egg tainting by brown-shelled layers is recessively inherited under typical 
commercial conditions 
 
Alison K. Ward, Henry L. Classen & Fiona C. Buchanan 
 
Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, 
Canada. 
 
Fishy-egg taint has long been a problem associated with feeding canola meal (CM) to 
brown-shelled laying hens.  It is caused by a SNP in the flavin-containing 
monooxygenase 3 gene (FMO3 984c.A>T).  This mutation prevents the fishy-smelling 
trimethylamine (TMA) from being oxidized to the non-odourous trimethylamine N-
oxide (TMAO), leading to an accumulation of TMA in developing egg yolks.  TMA is 
produced from the bacterial fermentation of choline in the gut.  Conflicting results from 
previous studies have found egg tainting to be recessive or additive.  Both studies fed 
high concentrations of choline chloride to induce tainting, which does not reflect 
commercial production practices.  Our objective was to characterize the inheritance 
pattern of fishy-egg tainting when hens are fed CM, reflecting typical industry practices.  
Diets consisting of 0, 6, 12, 18, or 24% CM were fed to 6 hens per genotype per diet 
(n=90).  Three eggs were collected per hen and the yolks were analyzed for TMA 
concentration.  The effects of diet, genotype, and their interaction were all significant 
(P<0.0001).  Only hens of the TT genotype displayed increasing yolk TMA 
concentration with increasing CM.  We therefore conclude that fishy-egg tainting is 
recessively inherited under standard CM feeding practices. 
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